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How Orexin Wakes the Brain 
Full Service Transplantation 






Christopher S. Leonard, 
Ph.D., and colleagues 
strive to understand 
the role of cholinergic 
neurons in sleep to 
help narcoleptics who 
can't stay awake.
S
leep, that universally revered and 
cherished part of our biological 
rhythm, is prized for its capacity to 
refresh and restore the human body and 
spirit. But as we age, menopause and 
prostate problems often interfere with this 
nightly bliss. The loss of this ability to fall 
fast asleep and remain in undisturbed slum­
ber can result in incomparable misery, it 
was not so long ago that insomniacs relied 
on homespun advice to get relief by drinking 
a glass of warm milk and not exercising or 
getting excited before bedtime. Medical sci­
ence, however, does not abide a vacuum. 
There are centers that have sprung up far 
and wide where clinical psychiatrists and 
psychologists combine psychology and 
electronics in a quest to understand and 
treat sleep/wake disorders.
Basic scientists have also been busy working 
to understand how the brain generates wak­
ing and sleeping. While there is still a long 
way to go, considerable progress has been 
made in identifying brain structures and neu­
rochemicals that are key players in this 
nightly neuronal drama. At New York Medical 
College, Christopher Sean Leonard, Ph.D., 
associate professor of physiology, concen­
trates on receptors and ion channels that 
populate part of the neural switch for control­
ling sleep.
Modulatory neurons
"The Holy Grail for us is to discover a 
substance that can provide the restora­
tive function of sleep, but without the 
downtime. This would allow people to 
operate all the time at peak efficiency 
without sleeping," Dr. Leonard explains. 
The military is interested in this for 
obvious reasons...
"As a cellular physiologist I began 
studying how cells work and espe­
cially, how nerve cells |neurons| com­
municate and information gets coded 
in the central nervous system. The vast 
majority of neurons in the brain are 
specialized for high speed processing 
of information, such as those in the 
visual system, which must accurately 
encode the intensity and motion of 
stimuli." However there also are other 
neurons specialized for slower modu­
latory roles, and they can completely 
change how the information process­
ing neurons work. "Indeed, these 
appear central to controlling waking 
and sleeping. But a lot less is known 
about these modulatory neurons since 
there are few of them and they are 
hard to find," Dr. Leonard says.
Cataplexy too
Ah, but Dr. Leonard does know howto 
find them and why they are important. 
His newest interest is narcolepsy, a 
life-altering sleep disorder that results 
in a patient falling asleep uncontrol­
lably throughout the day. Moreover, 
narcoleptics often suffer from an 
accompanying condition called cata­
plexy, which causes them to collapse 
in a heap on the ground, conscious 
and all but paralyzed.
"I'm interested in understanding how 
the brain makes us sleep and wake, 
how it produces these vast changes of
ABOVE: Physiologist Christopher S. Leonard, Ph.D,, takes time out from the patch-ciamp rig he uses 
for making sensitive electricai measurements from neurons in order to assay the activity of 
receptors and ion channels.
consciousness and why we undergo 
these changes from the neurologic 
point of view," Dr. Leonard begins. 
Specifically, he targets the cholinergic 
neurons found in the brain stem and 
the basal forebrain. Defined as neu­
rons that can synthesize the neuro­
transmitter acetylcholine, cholinergic 
neurons seem to be pivotal in estab­
lishing REM sleep and wakefulness. 
"There is lots of evidence that the 
hyperexcitability of these neurons 
causes an abnormal release of acetyl­
choline, which somehow triggers a 
cataplectic episode," he says.
A new peptide
Recently there has been rapid progress 
in understanding the neural basis of
narcolepsy. "About three years ago, two 
different laboratories wrote up animal 
studies that appeared in the journal 
Cell within weeks of each other," Dr. 
Leonard continues. "Both had discov­
ered that a peptide system never before 
linked with sleep and wakefulness was 
central to narcolepsy." A team at 
Stanford discovered that the gene for 
canine narcolepsy was a defective 
receptor for the neuropeptide hypocre- 
tin/orexin. The second group from the 
University of Texas Southwestern 
Medical Center at Dallas, which had 
previously co-discovered the peptide, 
followed with animal studies establish­
ing that loss of the peptide produced 
narcolepsy in test mice. (Hypocretin
(continued on page 19)
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This digital image from a brain slice demonstrates that the neuropeptide hypocretin/ orexin can excite cholinergic neurons 
(green dyed cells) that make the neurotransmitters acetylcholine and nitric oxide and play a key role in maintaining wakefulness. 
The electrical recordings at the top show activity from the neuron filled with red dye. Since the neuron also contains green dye, 
it appears yellow. Activity before (upper) and after (lower) hypocretin/orexin has been applied to the neurons reveals one way 
that orexin wakes the brain, a reaction absent in patients with narcolepsy.
Up and coming stars in the Department of Surgery are, from left, Elias Z. Zias, M.D., '89, who initiated a research program for the 
cardiothoracic division, and Laszlo Fuzesi, M.D., director of heart transplant at Westchester Medical Center.
Practicing emergency medicine in Afghanistan under the auspices of the U.S. Army gives new meaning to the specialty for 
Gerard P. Curran, M.D. '95.
CORRECTION: The Department of Surgery at New York Medical College was founded in 1860 by Jacob Beakley, M.D. Our thanks to Catherine 
N. Hinterbuchner, M.D., professor and chair of the Department of Rehabilitation Medicine, for bringing the error in the Spring/Summer 2002 
issue of Chironian to our attention.
FACULTY SAVVY AND RESEARCH GET 
HEART TRANSPLANTATION OFF TO A GOOD 
START AT WESTCHESTER MEDICAL CENTER
Surgery + Medicine + Luck Getting a Heart =
SURVIVAL
Y
ou may not remember where 
you were, but if you are of a cer­
tain age you have not forgotten 
the Sunday morning you heard that a 
South African surgeon named 
Christiaan Barnard had performed the 
first heart transplant on a human being. 
For those too young or not yet born, it 
happened in December 1967, when the 
handsome, 45-year-old cardiothoracic 
surgeon parlayed years of training by 
transplanting hearts in dogs into a mile­
stone event, it seemed, that would rival 
Edward Jenner’s discovery of vaccina­
tion. The recipient of the heart was 
Louis Washkansky, 55, suffering from 
diabetes and incurable heart disease, 
who lived 18 days before dying of double 
pneumonia as a result of his suppressed 
immune system.
Fast-forward to December 2002 and 
the 140 centers in the U.S. with the cre­
dentials to perform heart transplants. 
Westchester Medical Center, an acade­
mic medical center of New York 
Medical College that shares the 
Valhalla campus, is among the newest 
with five cases. It joins six others in 
New York where the 175 heart trans­
plants performed in 2001 make it the 
fourth busiest state in the nation. The 
statistics are provided by the United 
Network for Organ Sharing (UNOS) 
Organ Center, which recently cele­
brated 20 years of continuous opera­
tion. The organization was founded on 
the need to find kidneys and to pay for 
the cost of transporting them. It has 
been even more difficult to get hold of 
antigen-matched hearts.
PHOTO ABOVE: Patients in heart failure can be tracked by this new Bio-Z machine, which measures 
hemodynamics (blood flow) and fluid in the body. The machine provides a valuable, objective and 
non-invasive measurement of a patient’s progress, according to Warren Rosenblum, M.D., medical 
director of the transplant team at Westchester Medical Center.
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Short history
The groundwork had been laid for heart 
transplantation by two surgeons, 
Frenchman Alexis Carrel and the Russian 
S.V.P. Demikhov, who devised experi­
ments that proved the feasibility of 
transplanting an organ. Carrel lived at 
the turn of the century while Demikhov 
did his work in the late 1940s, but it was 
not reported in the West until 1962. The 
advent of techniques for open-heart 
surgery and the invention of the car­
diopulmonary bypass machine in the
Organ Procurement
and Transplantation Network
Heart Transplants Performed: January 1, 1988-June 30, 2002
All Donor Relations
All Centers 66
Albany Medical Center Hospital 8
The Presbyterian Hospital in New York City 33
Strong Memoriai Hospital 5
Montefiore Medical Center 4
Mount Sinai Medical Center 13
Westchester County Medical Center 3
Source; United Network for Organ Sharing
1950s were the stepping-stones to inge­
nious laboratory studies that were criti­
cal to blood typing and the matching of 
organ to recipient. As the decade ended, 
the surgical technique that is still being 
used today was developed by Richard 
Lower and Norman E. Shumway at 
Stanford University. All that was missing 
was effective immunosuppressive ther­
apy. The development of the drug 
Cyclosporin filled that niche and took 
the guesswork out of post-transplant 
medical care. Though the odds of living 
significantly longer after transplantation 
were poor at first, the numbers tell a dif­
ferent story now.
One patient is still alive after 24 years. 
Heart transplants performed with 1-, 
5-, and 10-year survival figures are now 
approaching 90 percent, 70 percent 
and 50 percent, respectively. In fact a 
transplant has almost become routine 
and ordinary. It is the intensity and 
quality of aftercare that is critical and
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exciting, as well as the invention of 
devices to keep a patient alive while 
waiting for a heart. The only unex­
pected thrills are those the surgeon 
sometimes is subjected to due to the 
lengths he must go to pick up the 
heart.
Not by UPS
Elias Zias, M.D., '89, assistant professor 
of surgery at New York Medical College, 
is a cardiothoracic surgeon and a mem­
ber of the transplant team. In 
September he flew in the middle of the 
night by helicopter to Allentown, 
Penna., to pick up a heart. The donor 
was an 18-year-old victim of a traffic 
accident; the recipient also was 18, with 
a congenital heart defect that had 
resulted in many surgeries at WMC. 
This very well paid deliveryman—when 
it absolutely, positively had to be there 
overnight (with apologies to FedEx)— 
is in his third stint at the College: med­
ical school graduate, surgical resident 
and faculty member. Dr. Zias went on to 
do two fellowships, a cardiothoracic 
surgery fellowship at Montefiore 
Medical Center in the Bronx, and a car­
diovascular thoracic surgery fellowship
at Children’s Memorial Hospital in 
Chicago. Besides his considerable 
research efforts he has performed more 
than 300 surgeries in 2001 alone, 
including valve and bypass, minimally 
invasive (beating heart) in cardiac, tho­
racic and vascular sites, and serving as 
a worthy first mate for Laszlo Fuzesi, 
the transplant surgeon who came 
aboard in December 2001.
Laszlo Fuzesi, M.D., associate professor 
of medicine, is director of the Heart 
Transplant Program at WMC. He was 
headed for this specialty the day he left 
medical school at Cornell University 
Medical College in New York City. 
Following an internship and residency 
in surgery at Thomas lefferson 
University in Philadelphia, and a resi­
dency in cardiothoracic surgery at The 
Presbyterian Hospital in New York City, 
he took a research fellowship in cardiac 
transplantation at Columbia University. 
As surgical director of the cardiac trans­
plant program at Newark Beth Israel 
Medical Center in New lersey since 
1990, he performed some 300 heart 
transplants, 30 lung transplants and 
surgeries involving more than 100 car­
diac-assist devices.
ABOVE: Laszlo Fuzesi, M.D., director of heart transplant at Westchester Medical Center, had 
transplanted more than 250 hearts, 30 lungs and performed 100 surgeries to implant cardiac assist 
devices by the time he arrived in 2000. It is the second start-up for the former surgical director of 
the transplant program at Newark Beth Israel Hospital, New Jersey’s only transplant program.
BETTER THINGS FOR SURGERY,
THROUGH RESEARCH
ABOVE: Elias Z. Zias, M.D. ’89, cardiothoracic surgeon and member of the transplant team at 
Westchester Medical Center, has initiated a research program for the Division of Cardiothoracic 
Surgery, Department of Surgery, at the College.
Surgeons have always had the bad rap that all they want to do is cut 
and then they’re gone. This dig, how­
ever, does not fit Elias Zias, M.D. ’89, 
assistant professor of surgery and a 
member of the heart transplant team. 
The tireless and demanding cardiotho­
racic surgeon is responsible for initiat­
ing a research program within the 
Division of Cardiothoracic Surgery. 
At iast count the team comprised two 
ciinical coordinators, two full-time 
surgeons doing research in animals, 
a pediatrician, a secretary, and col­
laboration with Kenneth Lerea, 
Ph.D., associate professor of cell 
biology and anatomy. Other alliances 
are in the works, but “I’m not in a 
position to reveal anything yet,” he 
says, barely able to contain and con­
ceal his enthusiasm.
At present he is principal investigator 
for six studies, mostly multi-center 
trials:
■ “Vasoreactivity of Arterial 
Grants to Vasopressors”
Funding is internal.
■ “Cerebral Optimization by 
Regionalization of the Aorta: A 
Randomized Study of Targeted 
Circulatory Management (TCM): 
Cardeon TCM-Cobra Catheter Trial” 
Funding by Cardeon.
■ “Cardiopulmonary Bypass”
Funding by Procter & Gamble.
■ “The MOSAIC Bioprostheses 
Efficacy & Longevity Trial”
Funding by Medtronic.
■ “A Phase III, Multi-Center, 
Randomized, Double-Blind, 
Placebo-Controlled Trial of the 
Ex-Vivo Treatment with CGT003 
of Coronary Vein Grafts—
Bypass Graft Procedures”
Funding by Corgentech.
■ “Modified Condensed Cardio­
pulmonary Bypass: Safety 
and Feasibility” Animal study with 
funding by Somanetios.
ABOVE: The Cardeon Cobra Catheter is a 
new entry in the effort to prevent strokes that 
occur as a result of heart bypass surgery. 
Elias Zias, M.D., has used the device in some 
140 operations with very promising results. Its 
ability to deliver cooled blood to the brain and 
warmed blood to the heart during a proce­
dure is being tested at 20 centers in the U.S.
“These trials are extremely impor­
tant for the very sick patients 
who are disabled due to conges­
tive heart failure and unable to 
function,” says John A. Savino, 
M.D., professor and chairman of 
the Department of Surgery, “The 
cardiothoracic division, with its 
large volume of cases, is thus 
afforded an excellent opportunity 
to explore these new techniques 
to salvage critically ill patients.This 
is consistent with a departmental 
initiative to perform research in 
areas where we already have clini­
cal superiority, and the expectation 
is that these efforts of the cardiac 
and cardiothoracic teams involved 
will contribute greatly to benefit 
these patients.”
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ABOVE: Heart transplant recipient Niall Maguire, right, of Putnam 
Valley, N.Y, represents the fruits of his labors to Matthew Pravetz, 
O.FM., Ph.D. ’88—theoretically, that is. As director of the Alumni 
Gross Anatomy Laboratory, Associate Professor Pravetz introduces 
medical students to their cadaver patients at commencement of the 
initial course of the curriculum. Maguire is the end product of a 
number of advances in medical science. A defibrillator saved his 
life, and a cardiac assist device kept him going until a transplant 
was able him to give him back a life.
Takes time
"It takes five or six years to establish a 
transplant program," Dr. Fuzesi declares 
of his second time around in starting 
one. "People have to be patient. 
Sometimes if you rush thi/igs it affects 
the outcome. Heart surgery has been 
here a long time and we're just adding 
another tool to the armamentarium... 
Westchester had everything but heart in 
its transplant program. Now we have a 
full house and the ability to manage end- 
stage heart disease."
At Newark Beth Israel, he not only 
developed New lersey's only transplant 
program, but also recruited, initiated 
and developed the mechanical sys­
tems involved in holding off end-stage 
heart failure. Once considered only as 
a bridge to transplant, these heart 
assist devices are now being evaluated 
for permanent use. They include the 
left ventricular assist device (L-VAD), 
the HeartMate and the Abiocor. So far 
the results have been mixed. (The FDA 
approved the HeartMate in November
as a permanent treat­
ment for patients too 
sick for transplants.)
"1 still believe assist 
devices are better than 
total artificial replace­
ment," Dr. Fuzesi admits, 
"because we’re still hav­
ing trouble with them 
because of strokes and 
infection."
Aftercare
The third peg in the tri­
umvirate is Warren 
Rosenblum, M.D., who 
left the University of 
Pittsburgh School of 
Medicine to join the 
WMC transplant team 
in lune. As its medical 
director as well as 
overseer of all patients 
in heart failure and 
post transplantation. 
Dr. Rosenblum deals 
mostly with patients in 
severe heart failure 
who have been referred by cardiolo­
gists. (After they are stable, he insists 
they return to their referring cardiolo­
gist for continued care.)
Following graduation from the Albert 
Einstein College of Medicine in the 
Bronx, Dr. Rosenblum did his intern­
ship, residency and fellowship in heart 
transplant medicine at The lohns 
Hopkins University. For two decades, 
the internist who is also certified in car­
diovascular diseases, has been studying 
the neuro-hormonal mechanisms of 
congestive heart failure in order to mod­
ify the body's response through molecu­
lar immunology. "1 was looking at using 
gene therapy in preventing transplant 
rejection, and the role of cytokines and 
dendritic cells to prolong graft survival," 
he says. "I've been building up a large 
human heart tissue bank, with close to 
300 samples given with consent by 
patients, in order to identify changes in 
the levels of gene expression measured 
at the point of most severe versus clinically 
improved—at the time of transplant."
Eager to resume his research, he is 
working on getting lab space now that 
the hospital service is up and running.
His job
Following a hospital stay of only eight 
to fifteen days, the recipient of a new 
heart can have a normal quality of life 
after staying home for only six weeks. 
"Nobody leaves the hospital without 
one clean biopsy," Dr. Rosenblum 
explains, to make sure there are no 
signs of rejection or infection. After that 
weekly biopsies become monthly and 
then are done every three months. "If 
everything is all right after five years, we 
could stop them altogether," says Dr. 
Rosenblum. "We do the biopsies 
through a vein in the neck into the right 
ventricle to look for signs of rejection 
before symptoms even occur."
The living proof is Niall Maguire, 56, 
of Putnam Valley, N.Y., recipient of 
the first heart successfully trans­
planted at Westchester Medical 
Center. (The first candidate died from 
renal and vascular conditions that 
had nothing to do with the surgery.) 
When the Irish gentleman was 
brought by ambulance from Putnam 
County he was dying in heart failure. 
A ventricular assist device saved his 
life, and after a couple of months, he 
was ecstatic when the call came that 
a heart in Queens was a match. After 
10 days in the hospital, the spunky 
Maguire went home.
Six weeks later he was back behind 
the wheel of the limousine he drives 
to airports, theatres and all those 
places his customers don’t want to. 
Armed with anti-rejection medicine 
and steroids, Maguire has added 
forty pounds and says he feels as well 
as the day he immigrated to America 
at the age of 18. Only one thing both­
ers him. He had requested and 
received the name and address of the 
donor’s family, which is permitted 
one year after transplant. Contacting 
the family is something he wants to 
do, but just can't. ‘Tve got to do 
this," he knows, "but I'm just not 
ready, you know, to thank them for 






ABOVE: Charles T. Stier, Jr, Ph.D., associate professor of pharmacology, has written numerous 
papers on his NIH funded research showing the positive effects that ACE inhibitors and angiotensin 
receptor blockers have in preventing vascular injury. His recent studies indicate that blocking 
aldosterone receptors can have a major impact on reducing myocardial infarction, stroke and 
kidney failure in hypertensive rats.
Charles T. Stier, 
Jr., Ph.D., uses 
ACE inhibitors to 
blunt the effect 






here’s an old saying that 
there is always something 
new to learn, even if you are 
an expert in the area. In medical sci­
ence this is a certainty, where long­
standing beliefs are regularly 
expunged and new insights revealed 
to researchers who often spend their 
entire careers in one field of study. 
Blood pressure (BP) is a good exam­
ple. Rev. Stephen Hales of England 
was the first to measure it more than 
300 years ago by sticking a glass 
tube in an artery of the neck of an 
obliging mare. Physicians knew little 
about the pathogenesis or implica­
tions of untreated hypertension until 
the late 1970s, when they began to 
recognize it was a major coronary 
risk factor. Under the auspices of a 
national committee dedicated to its 
research, hypertension was divided 
into three levels: mild, moderate and 
severe, which later were renamed 
stages I, II and III. That group, impe­
rially named the loint National 
Committee on Prevention, Detec­
tion, Evaluation and Treatment of 
Hypertension, also established a BP 
of 140/90 mm as a threshold, but 
reduced the number to 130/85 for 
those with diabetes; organizations
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devoted to kidney and diabetes 
research further iowered the number 
to 130/80 for patients with those ills.
Drugs help
And so began the search for antihy­
pertensive medications that could 
lower blood pressure when drugless 
options such as weight loss and exer­
cise failed, either because patients 
wouldn’t or couldn’t comply. Without 
medication, this silent disease pre­
senting no symptoms even while it is 
causing life-threatening or fatal dam­
age, continues to undermine the car­
diovascular system and prime the 
body for a heart attack, kidney disease 
or stroke.
When Charles T. Stier, Ir, Ph.D., became 
a member of the New York Medical 
College Department of Pharmacology in 
1981, he joined a group of investiga­
tors who live and breathe the study of 
cardiovascular disease in general and 
hypertension in particular. Recruited 
by lohn McGiff, M.D., (see story on page 
12), professor and chairman. Dr. Stier 
left the University of North Carolina at 
Chapel Hill where he was an NIH 
postdoctoral fellow before becoming 
an instructor in physiology. The asso­
ciate professor has spent 20 years at 
the College, half the time busy with 
teaching and curriculum duties for the 
medical and basic science students to 
be served. The other 50 percent of his 
time he covets for research, for the 
most part funded by the NIH. His pre­
sent grant for $910,724 entitled 
"Prevention of Stroke Dysfunction by 
ACE Inhibitors" runs until September 
30, 2003. ACE (angiotensin-converting 
enzyme) inhibitors are now a mainstay 
in the treatment of hypertension, hav­
ing become a key component of the 
cardiologist’s armamentarium for 
combating heart failure, and proving 
effective in preventing the loss of pro­
tein in the urine. It was Dr. Stier’s 
studies in rats with hypertension that 
offered the first compelling evidence 
that ACE inhibitors could prevent 
damage to the heart, kidney and brain 
without lowering blood pressure.
Diuretics first
Medical progress doesn’t exclude the 
use of tried and true remedies, and so 
it is that alone or together with newer 
therapies, a diuretic is usually the 
first drug to be prescribed. It brings 
blood pressure down by reducing the 
volume of fluid the heart has to pump 
through the body, provided there is 
no underlying disease to preclude its 
success. Beta-blockers, which slow the 
heart and reduce the force of its con­
tractions, may also be an initial drug 
of choice for patients who already 
have had a heart attack or are known 
to have coronary artery disease.
A cardiologist also selects from vaso­
dilators and calcium channel blockers, 
blood vessel relaxers and angiotensin 
receptor blockers that work in a similar 
way to ACE inhibitors. But all of these 
drugs must be prescribed selectively 
due to their side effects, and that is 
especially true for ACE inhibitors, 
which can cause a stubborn cough, a 
rash and in fewer than 1 percent, angio- 
edema, a swelling of the neck that can 
result in suffocation. But despite the 
drawbacks, ACE inhibitors rate as first 
choice for the treatment of hyperten­
sion and congestive heart failure, and 
have great potential in other situa­
tions, Dr. Stier claims. He modestly 
mentions being "the first to elucidate 
the process of what else they can do."
The use of ACE inhibitors following a 
heart attack was validated recently in 
an article by Lawrence K. Altman, 
M.D., in The New York Times. His 
November 26th column "The Doctor’s 
World" in the "Science Times" section 
made mention of their inclusion in 
guidelines for treatment by the 
Amercian Heart Association as well as 
the American College of Cardiology.
ABOVE: Weighing out 200 mg of spironoiactone on an analytical balance In his iaboratory, 
Charles T. Stier, Jr., Ph.D., uses the synthetic steroid as an aldosterone receptor blocker. His 
ongoing studies of aldosterone suggest the adrenal hormone not only leads to hypertension, but 













The schematic diagram illustrates how therapeutic interventions can protect against vascular injury 
and the inevitable stroke, coronary or kidney damage. 
Dr. Stier used hypertensive rats that spontaneously 
develop strokes to test the effectiveness of ACE 
inhibitors and AT1 (angiotensin-1 converting enzyme) 
in providing protection against vascular injury. After 
observing a minimal lowering of blood pressure, he 
considered the possibility that Ang II (angiotensin 
receptor blocker) was working through its known 
potent action to stimulate the release of aldosterone 
by the adrenal glands. Dr. Stier persistently treated the 
animals with aldosterone receptor blockers such as 
spironolactone and epierenone, noting marked bene­
ficial effects. These studies identified aldosterone as a 
major cause of organ damage in the animals.
Real benefit
Dr. Steir has found that ACE 
inhibitors can prevent myocardial 
infarcts, strokes and kidney damage 
due to its ability to diminish the for­
mation of aldosterone, a relatively 
new villain in heart disease. 
Aldosterone, an adrenal hormone, is 
a refugee from the evolution to ter­
restrial life. Leaving behind the sea— 
a continuous source of salt and 
water—meant adapting to land and 
developing mechanisms to preserve 
salinity. Aldosterone, the main 
sodium-retaining hormone released 
by the adrenal glands and a big player 
in the body’s system to regulate 
blood pressure, fits the bill. It does 
its dirty work by increasing the reab­
sorption of sodium and water in the 
kidneys at the same time it is stimu­
lating the excretion of potassium—all 
causing blood pressure to rise. 
Equally as destructive is the manner 
in which it lures calcium into blood 
vessels, although this process does 
not involve the kidneys.
Vascular disease affects every layer in 
a blood vessel—endothelium, smooth 
muscle and adventitia—and aldos­
terone negatively influences all of 
them. Dysfunction of the endothelium 
(inner layer) has been linked to an
increased risk for cardiovascular 
events, to blood vessel stiffness and 
constriction of the smooth muscle 
layer. In the adventitia, there is evi­
dence that aldosterone can induce 
fibrosis in the heart and vessels. The 
resulting vascular stiffness can cause 
systolic hypertension, recently recog­
nized as a major insult for people over 
the age of 50. What’s more, aldos­
terone can intensify blood clotting; 
the consequences include tissue 
ischemia, infarction and fibrosis.
Receptors and 
blockers
One aldosterone blocker Dr. Stier works 
with is spironolactone (Aldactone), a 
synthetic steroid with a structure so 
similar to that of aldosterone that it 
can act as a competitive antagonist at 
aldosterone receptors. "Although it is 
not a first line agent for the treatment 
of hypertension,’’ Dr. Stier advises, 
"spironolactone has been reported to 
produce marked blood pressure lower­
ing that may not be accompanied by 
the fluid and electrolyte loss some 
others of its type cause.’’
His antagonist of choice actually is 
epierenone (Inspra), an aldosterone 
receptor antagonist with the moniker 
selective aldosterone blocker (SAB).
So promising is this drug it received 
FDA fast track approval in September 
due to the "great therapeutic value it 
showed in preventing cardiovascular 
disease and associated end-organ 
damage,’’ he advises. And it is effec­
tive without displaying spironolac­
tone’s occasional side effects of men­
strual irregularities, impotence and 
gynecomastia, the over development 
of male breasts. "Although Inspra 
was approved only for use in hyper­
tension, there are several ongoing 
trials now that suggest other indica­
tions are in the wings," says Dr. Stier, 
"and that is very exciting." In one trial 
Inspra is being tested as a post-coro­
nary therapy, he reveals, and he 
should know from having assisted 
the manufacturer, Pharmacia, in the 
basic science studies that indicated 
it had the potential to be a cardio­
vascular agent.
Dr. Stier has worked before with 
prominent pharmaceutical compa­
nies in regard to animal studies. "I 
never do an experiment with the 
thought of developing a drug,’’ he 
says, "but that has been the case with 
epierenone. Researchers don’t think 
that what they are doing will neces­
sarily be used on patients, but if it 
happens, it happens." □
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ABOVE: As a favor to his disciple Michal L, Schwartzman, Ph.D., John C. McGiff, M.D., agreed to 
be photographed for an articie on Dr. Schwartzman in the previous issue of Chironian. Dr. McGiff 
has been the architect of the Department of Pharmacoiogy for the iast 23 years.
In a nutshell, Dr. McGiff is a resolute, 
uncompromising and sovereign scholar 
who sets the pace in Pharmacology as 
surely as if he waved a checkered flag 
to start the day. One of six basic 
science departments at New York 
Medical College, Pharmacology is 
granted more research dollars than any 
other. The research faculty, who also 
teach what amounts to the last course 
in the second year of medical school, 
are convinced that Pharmacology is 
the most valuable.
How things work
In the clinical arena. Pharmacology has 
been the basic science leader in bench- 
to-bedside collaborations, such as the 
ongoing study by researchers in gene 
therapy and the hematologic oncolo­
gists who try fervently to control 
leukemia. Yet, as the bioscience most 
folks can relate to, pharmacology— 
which investigates the effects of drugs 
on living organisms—is not what turns 
on Dr. McGiff.
(tl have always 
received support from 
administration.
There have been no 
barriers to academic 
pursuits. This proved to be 
an environment that 
allowed the department to 
develop along the 
best possible paths and 
I’ve been able to recruit 
first class scientists. 5 J
"Mechanisms," he says. "I like mecha­
nisms. The goal in science is to follow 
the next lead because there is no end. 
Knowledge is an end in itself...To dis­
cover a new drug? Oh, I'm pleased when 
it happens, but that's for someone else 
to do. I work on lipid modulators and 
the mediators of basic mechanisms."
In the 1990s Dr. McGiff began focusing 
on the relationship of vasoactive hor­
mones to eicosanoid (fatty acid)-depen- 
dent mechanisms regulating vascular 
tone (constriction or dilation), and salt 
and water excretion. His work focused 
on the physiology and biochemistry of 
novel metabolites of arachidonic acid 
derived from enzymes called cyto­
chrome P450 monooxygenases in the 
kidney and blood vessels.
Against the tide
"We were a voice crying in the wilder­
ness," says Dr. McGiff. "Cytochrome 
P450 and arachidonic acid metabo­
lism—we started this field in terms of its 
extension to cardiovascular and renal 
studies based on a suggestion of Dr. 
Nader Abraham to a very bright Ph.D. 
student. Dr. Nicholas Ferreri, now a staff 
member of the department. It's the third 
pathway of arachidonic acid metabo­
lism." (For the Ph.D.s in the reading 
audience, the first and second pathways
are cyclooxygenase and lipoxygenase.) 
Since 1985, Dr. McGiff and his team have 
been investigating the vascular and 
renal mechanisms of blood pressure 
regulation. An initial NIH Program 
Project Grant for "Hormonal Regulation 
of Blood Pressure" was earned by Dr. 
McGiff, with an assist from Drs. Michal 
L. Schwartzman and Mairead Carroll. Dr. 
Alberto Nasjletti took over as principal 
investigator of the grant in 1995. He will 
be courting another renewal in 2005, 
when the grant will be 20 years old and 
a fifth five-year term is sought for fund­
ing. This is what Dr. Nasjletti has to say 
about his friend and boss:
"lack McGiff is one of a kind, a passionate 
scientist with the soul of an artist, a man 
not bound by conventions who is always 
ready to stand up for what he believes; a 
fair, sensitive and generous friend and 
colleague who often hides behind a 
rough exterior; a man for all seasons who 
approaches life and work with the enthu­
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siasm of a 20-year old. We are fortunate 
to have lack McGiff as our chairman. I 
have no doubt that he is tops!"
Dr. McGiff feels the same way about his 
superiors: "I have always received sup­
port from administration. There have 
been no barriers to academic pursuits. 
This proved to be an environment that 
allowed the department to develop 
along the best possible paths and I've 
been able to recruit first class scientists, 
including colleagues from the '70s," 
says Dr. McGiff. He is referring to Drs. 
Patrick Y-K Wong and Nasjletti. The trio 
has'worked together since the early '70s 
at the Medical College of Wisconsin and 
later, the University of Tennessee.
Beautiful friendships
At the time. Dr. McGiff was interested in 
prostaglandins vis-a-vis blood flow to 
organs, salt and water excretion in the 
regulation of circulation and renal func­
tion, and their relation to hypertension, 
congestive heart failure and liver and 
kidney diseases. A good friend by the 
name of Gabor Kaley, then and still chair 
of the College Department of Physiol­
ogy, let him know there was a vacancy 
for the chair of pharmacology.
"Sally couldn't stand Memphis and nei­
ther could I," says Dr. McGiff in recalling 
why he and his late wife jumped at the 
offer to leave the University of Tennessee 
Center for the Health Sciences where he 
was chairman of the department of phar­
macology. Since four years was about as 
long as Dr. McGiff had remained in any 
medical school position—which over 
previous years had included Columbia 
University, University of Pennsylvania, 
St. Louis University and Tennessee—the 
opportunity to move back north was 
very attractive.
"1 left most of those positions because 
the deans raised barriers to the pursuit 
of academic goals," he insists. "One of 
them even took my hard dollars!" That 
incident made him so angry he 
uprooted the family and went abroad for 
"our English period." For two years his 
children attended English schools while 
he reveled as a visiting scientist at 
Wellcome Laboratories at the behest of 
Nobel Laureate lohn Vane.
Nobel prize
Sir lohn shared the Nobel Prize for 
Medicine or Physiology in 1982 for 
demonstrating that aspirin suppresses 
the production of local hormones 
known as prostaglandins; this funda­
mental work eventually led to the devel­
opment of the Cox-2 inhibitors 
Celebrex® and Vioxx®. He and Dr. McGiff 
still maintain a close relationship and 
every few years the College community 
is updated on Cox inhibitors in a visit­
ing lecture from Sir |ohn who inciden­
tally, holds a faculty position at New 
York Medical College. That Dr. McGiffs 
name was mentioned in the Stockholm 
ceremony by Sir lohn is not surprising, 
considering his suffer-no-fools style in 
life. "My brother took over the family dry 
cleaning business because 1 had no 
interest in the commercial world— 
none! My father was the quiet one, the 
major influence in my life, who never 
interfered." he says. "1 selected the col­
lege, the medical school, and he paid."
Dr. McGiffs dachshund Lucia.
Dr. McGiff finished his B.S. at 
Georgetown University in three years, 
and entered Columbia’s College of 
Physicians and Surgeons at the age of 
19. After an internship at the University 
of Cincinnati and residencies in medi­
cine—first at the University of Virginia 
and then at Pennsylvania Hospital—he 
opted for a fellowship in cardiology at 
the University of Pennsylvania.
All work and play
There were other major influences in 
his life that filtered through this inter­
view—his two-year stint from 1955- 
1957 as a flight surgeon with the Fleet 
Marine Force in Korea and lapan ("They 
were great drinking buddies!"); Sara 
(Sally) Leighton Babb, his wife of 32 
years ("She taught high school English 
and drama and she was a pretty good 
horsewoman and a superb mother, 
too."); Samuel Rubin, dean of the 
School of Medicine ("He was the key 
figure in recruiting me, being direct and 
supportive, and having all the virtues of 
an admirable man. He made my deci­
sion easy...His word was his bond.").
Dr. McGiff has accumulated all the trap­
pings of scientific success: voluminous 
publications, committee appointments 
and awards, memberships in societies 
and on editorial boards and enough 
honorary lectureships to keep him on 
the go. is he satisfied?
Adversity is good
"There have been some bad moments— 
rejected manuscripts and lost grants. 
But we overcame. And when you do, 
you feel better for it. 1 like adversity! 
However, there was compensation in the 
form of five interesting and challenging 
sons and daughters...
"I've had a great time. No one took away 
my toys. Science is the greatest game on 
earth. Worldwide I've made the most 
intriguing friends... Science demands your 
total attention and it’s a great ride. You 
break your neck and it's worth it...The 
department is a great showcase for tal­
ented and dedicated scientists and staff 
and I’m in their debt.
"I live for the good times. As long as 1 
can run and jump, and drink—1 think 
Americans are preoccupied with 1 
ounce a day, and all of the forces of 
darkness (Biblical prohibitions, smok­
ing, dieting, driving 55 miles an hour). 1 
say living well is the best revenge!”
Now he is through talking, except for 
his patented showstopper: "Everyone 





The School of Public Health and Rockland County design a telephone
survey to examine its high rate of breast cancer.
T
wo years ago, Rockland 
County had the dreadful dis­
tinction of having the highest 
rate of new breast cancers in New York 
State. Women on Long Island had 
long been told that tfieir rate was 
unusually high, but the results of a 
study authorized by Congress in 1993 
has found otherwise. A statistical 
analysis released only last August 
showed that Long Island rates were 
not much different from those in the 
rest of the country. What is more, the 
$30 million trial failed to find any
links to pollution or other environ­
mental factors for cause. Though the 
results of this study turned out to be 
negative, the search for causes of 
breast cancer are more than worth­
while. Breast cancer is the leading 
cause of death in women aged 34 
to 55, killing more than 40,000 across 
the nation each year, and the numbers 
have increased steadily in recent 
years. The risk of contracting the 
disease at some point in a woman's 
life is 1 in 8, versus 1 in 22 just 50 
years ago.
In the "Breast Cancer Screening 
Project of Rockland County" that 
began in February, epidemiologists 
are looking at the disease on a much 
smaller scale and from a different 
angle. Principal investigator is Paul 
Visintainer, Ph.D., program director, 
health quantitative sciences, in col­
laboration with Cathey E. Falvo, M.D.,
M.P.H., program director, interna­
tional health and public health; and 
Susan Goodwin, Ph.D., assistant pro­
fessor of health sciences and associ­
ate program director of environmental
ABOVE: The data is in and under analysis by epidemiologists investigating Rockland County women and their attitudes on mammography and breast 
cancer. Representing the School of Public Health are, from left standing, Susan Goodwin, Ph.D., M.RA., assistant professor and associate program 
director, environmental sciences; Paul Visintainer, Ph.D,, program director, health quantitative sciences; and at right, Sheila Smythe, executive vice 
president and dean. The Rockland contingent includes Kathleen Henry, B.S.N., M.A, second from right, public health administrator; and Joan Facelle, 
M.D., seated, commissioner of the Rockland County Health Department and M.RH. candidate in the School of Public Health.
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health sciences, in the School of 
Public Health at New York Medical 
College. The Rockland County Health 
Department, led by Commissioner 
loan Facelle, M.D., has awarded a 
grant of $70,000 to the School of 
Public Health to survey 2,000 of the 
estimated 80,000 women living in the 
county who are 40 and over.
The questions
"We want to know what proportion of 
women have ever had a mammogram, 
and what proportion have regular mam­
mograms," says Dr. Visintainer. "Before 
attempting to identify the risk factors 
for breast cancer, specifically in 
Rockland County, we wanted to exam­
ine factors that might influence the 
numbers. For example, there are issues 
surrounding detection and surveillance. 
The more you look for something the 
more you find it. So if Rockland women 
have a heightened awareness and are 
more likely to get mammograms regu­
larly, the better their chances of detect­
ing it early on. And that's good...
"This is what happened with the PSA 
(prostate specific antigen] test and 
prostate cancer. In a two-year period the 
incidence jumped. The PSA was detect­
ing cancer earlier and picking up previ­
ously undiagnosed cases, which meant 
adjusting the baseline for newly
detected cases... As epidemiologists, 
we try to identify the causes of elevation 
in the occurrence of a disease. Some­
times these are risk factors, sometimes 
they are changes in technical or popula­
tion characteristics such as behaviors or 
demographics, and sometimes both."
Sampling technique
The survey produced 1,600 responses 
from Rockland women by the time 
sampling stopped at the end of 
September. The 10-15 minute tele­
phone survey was composed of 70 
questions (down from an original 150), 
and the results were broken down by 
age, demographic characteristics, gen­
der and ethnicity, among other factors.
"The questions dealt with their knowl­
edge, attitudes, beliefs and behavior 
regarding breast cancer and screening," 
explains Dr. Visintainer. "The response 
rate was good—more than 70 percent." 
The survey questions were adapted from 
an NIH study on breast cancer, from the 
project team, and from Dr. Facelle, who 
coincidentally is an M.P.H. candidate in 
the School of Public Health.
A preliminary analysis of the data began 
at the end of September, Dr. Visintainer 
reveals. Dr. Goodwin has been analyzing 
the results, while Dr. Qiuhu Shi, associ­
ate professor of health sciences and
senior biostatistician, helps Dr. 
Visintainer develop statistical models 
to determine what proportion of the 
incidence of breast cancer in Rockland 




"One of the first things we will do is to 
compare the demographics of survey 
respondents with census data on 
Rockland to see how well they agree, giv­
ing us confidence that our survey is rep­
resentative of Rockland County women 
over 40. Our initial look shows they agree 
quite well. This will also help us to iden­
tify sub-groups in the population," says 
Dr. Visintainer. "The next step will be to 
look at the overall rates in mammogra­
phy screening by demographics (age, 
ethnic groups], and then determine how 
attitudes and beliefs make a person 
compliant for screening.,.
"Our intention is to use this as a frame­
work for developing new research initia­
tives such as multi-county compar­
isons, providing estimates of how the 
screening rate affects the reported inci­
dence of breast cancer in the county, 
and all in all, helping women to more 
realistically view their risk of breast can­
cer in Rockland County." D
Ira S. Schwartz, Ph.D.,
Appointed Chairman of the Department of 
Microbiology and Immunology
If the name Ira S. Schwartz, Ph.D., the new chairman of the Department of Microbiology 
and Immunology, sounds familiar, it should. He spent 22 years in the Department of 
Biochemistry and Molecular Biology, three as acting chairman. A full professor since 
1989, he succeeds Felix Wassermann, Ph.D., professor, who had been acting chairman 
since 1999. Dr. Schwartz will maintain a secondary appointment in medicine and a tertiary 
appointment in biochemistry and molecular biology.
He is internationally known in the field of molecular pathogenesis of infectious diseases 
for his pioneering studies in the tick-borne infections of Lyme disease and ehrlichiosis. 
Dr. Schwartz is principal investigator of studies funded at nearly $2 million by the 
National Institutes of Health and the Centers for Disease Control and Prevention.
A graduate of the City College of New York, Dr. Schwartz earned a Ph.D. from the City 
University of New York and completed a two-year postdoctoral fellowship at the Roche 
Institute of Molecular Biology in Nutley, N.l.
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9/11: THEN AND NOW
Nothing like it had ever happened in America. The symbol of prosperity was burning, 
some 3,000 of its occupants doomed to die. And then, one after the other, the towers of the 
World Trade Center fell down—right in front of our eyes. Not a single person in the 
United States old enough to understand the implications of the attack was left untouched. 
And as they reflect upon then and now, these New York" Medical College students 
who had extraordinary experiences are no different in taking it personally.
Laura Fasulo, Class of '05, had moved from San Diego just two months before 
with her new husband, Rusty, a detail man with Glaxo Smith Kline. A former clinical 
research coordinator for Affiliated Research Institute, she had waited five years after college 
to be really sure she wanted to go to medical school. And here she was, standing outside 
on such a beautiful morning in September because the Basic Sciences Building had emp­
tied from a false alarm. "Wouldn't it be wonderful If classes were cancelled for the rest of 
the day?” she remembers asking no one in particular. Less than two hours later they were, 
when the president, provost and dean interrupted their lecture to inform them about what 
had happened. "We all went to the lobby and the TV was on," she whispers. "Within min­
utes the first tower collapsed and I instantly started to cry, and I didn’t even know anybody 
who worked in the building. When I finally got home Rusty was there. He had been told to 
stay home. 1 sat in front of the TV for the rest of the day and for two weeks after that. This 
was the first time I will always remember where I was when it happened. I didn’t get to New 
York City until February and by that time there was nothing to see, but it bothered me that 
street vendors were capitalizing on peoples' miseries. Still, I loved seeing the flags on cars 
and people were so nice to each other—and that’s a lot to say for New Yorkers.”
Natasha Bamji, Class of ’06, was doing leukemia research at the NIH in Bethesda. 
The proud recipient of an Intramural Research Training Award, she was planning on graduate 
school and had been working only two months at the Warren Grant Magnuson Clinical 
Research Center—about a half-hour with traffic away from the Pentagon. Someone watching 
TV began running around, spreading news of the disaster there, and within minutes everyone 
was watching at the nearest screen just in time to see the second tower fall. "Everyone had 
relatives in Washington," she recalls, "at the White House and the Capitol Building. What 
would be next? There was even a rumor of a car bomb outside Congress. Then the loud 
speaker came on telling everyone to evacuate the building. With 51 buildings on the NlH cam­
pus, we could be the next target." It was chaos in the parking lots, with 18,000 cars on cam­
pus all trying to leave at once. She left her car and walked to the house of a friend. "I never 
felt danger myself. It seemed such an impossible thing,” she says. "In thinking back 1 was in 
danger, but it seemed so surreal then. Now the country has moved on and that’s what we have 
to do. We have to focus on the positive and not let the terrorists get the better of us.”
Natasha Bamji
Laura Fasulo
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Richard A. Occklcr, M.S. ’97, Ph.D. '02, class of 04, a volunteer lieutenant 
in the Tarrytown Fire Department, lives next door to his firehouse. He saw the second 
plane hit on TV and within five minutes received a disaster page. While his buddies headed 
for Manhattan, he was left in charge of an area that extended from Dobbs Ferry to 
Ossining. The next day he got only as close as two blocks from Ground Zero, but he still 
recalls the "stories of rubble” he saw before being reassigned to cover Ladder 37 in the 
Bronx for the next week. "At first I was very angry," he admits. "I'm a downtown kind of guy 
and it was very personal. I was born in New York City, the center of the universe, and they 
had hit a part of me." Despite having to prepare his thesis defense, he "found it took a long 
time, two months at least, before my first thoughts were not on the World Trade Center. 
I channeled a lot of myself into my thesis |on cardiovascular physiology], and eventually 
the anguish was replaced by a numb sensation...! think the best memorial would be to 
rebuild the tpwers exactly as they were. It doesn't look like New York anymore...It's 
changed everything for me, and like it or not, it has forced me to be more aware of other 
cultures and beliefs. How can you contend with people who want to die for their religion?"
Richard A. Oeckler, Ph.D.
Travis J. Kemp, Class of '04, better known as T.|., is from Boise, Idaho. He had 
visited the towers with his girlfriend merely five months before 9/11, when they took a tour 
that included the top of the World Trade Center. 'Tm glad we had the experience,” he says, 
looking far away. "I was getting ready to go to class when my roommate knocked on my 
door. I thought it was an accident from a private plane. I watched the events unfold with 
my roommate in his room and we saw the second explosion. At that point, without even 
speaking to each other, we both knew it was no accident. We sat in shocked silence. We 
went to class but there weren't many people in Blue Auditorium. Then Dr. Zachrau came 
and cancelled class, and I went to the TV and watched some more. I felt pretty disori­
ented, not knowing what to do. People began to cry when the first tower collapsed and 
then the second one came down. I was in a bit of a hysterical mood. A bunch of us went 
to Westchester Medical Center to give blood, but there were so many people we never got 
to give it. Even at Sam's Club there were too many for them to handle in the blood drive. 
In thinking about it now, I remember the pictures my girlfriend and I took at the towers. 
Her next trip in we had a bittersweet visit to Ground Zero—just to remember the place 
where we had had such a good time, and yet had such a terrible thing happen.”
Travis J. Kemp
Athena Lee. M.RH.
Athena Lee, M.P.H. candidate in Emergency Medical Services (EMS), School of 
Public Health, is a paramedic certified in advanced life support. Having worked an 
overnight shift, she was taking a nap in the crew's quarters when her supervisor burst in 
with the news. It was no joke. In minutes the crew was in an ambulance headed over the 
Brooklyn Bridge and the sky was black, "like all of lower Manhattan was on fire," she shud­
ders. "The bridge was jam-packed with people exiting the city, like in a movie. They're 
going out and we're going in. I suddenly realized we might not come out alive.” Soon they 
were assigned to the staging area, but "there were no critical patients. I've never seen any­
thing worse. If those people hadn't or couldn't get out and walk away, they died. We 
weren't allowed near Ground Zero because it was too hot—in every sense of the word. We 
actually worked over 24 hours before they made us leave, but at the debriefing nobody 
could talk about what happened. Most of us just felt numb. We're trained to work in an 
automatic mode, but there was such a feeling of helplessness. It may be buried now, but 
it’s still there and obviously, the anger is still there, too," she confides. "I still have a feel­
ing of rage. We were powerless and had a sense of no control. We've dedicated our lives 
to doing something for people and here we couldn't do a thing.”
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ABOVE; After Kristi Kohimeier, Ph.D., completed a post-doc in the 
laboratory of Christopher S. Leonard, Ph.D., she opted to stay on 
with her mentor. Here they are engrossed in studying a mouse 
brain section stained for the neurotransmitter serotonin^ The 
special mouse was engineered at the University of Texas 
Southwestern Medical Center to be lacking receptors for orexin, a 
peptide recently found to be missing in people with narcolepsy.
narcolepsy (continued from page 3)
and orexin are the same peptide. Using 
both names together acknowledges the 
simultaneous discovery by two groups.)
Christopher Leonard was fascinated by 
cholinergic neurons well before he 
joined the College in |uly 1997 from 
New York University, where he earned 
masters and doctoral degrees in physi­
ology and biophysics. (Perhaps his 
undergraduate degree in psychology 
from Northeastern University in 
Boston is responsible for the warm and 
patient persona he displays.) He is 
supported by two NIH grants totaling 
$2.2 million, and has been assisted by 
numerous graduate students and post­
docs including Kristi Kohimeier, Ph.D., 
a research associate who recently com­
pleted her NlH-funded post-doctoral 
fellowship in Leonard's laboratory. Dr. 
Leonard's name appears regularly at 
scientific conferences attended by 
sleep researchers from around the 
world who have no qualms about 
praising his work.
Colleague praise
One of these is Dr. lerry Siegel, a profes­
sor of psychiatry at UCLA and chief of 
neurobiology research at the Sepulveda 
VA Medical Center. Dr. Siegel is distin-
cause of human nar­
colepsy, and he has 
this to say about Dr.
Leonard's research;
"It's superb work. Dr.
Leonard has very cleverly 
combined molecular 
and 'in vitro' techniques 
to achieve a major break­
through in our under­
standing of this newly 
discovered peptide. His 
finding that hypocretin 
controls certain other 
neurotransmitters, espe­
cially one called gluta­
mate, shows that it may 
coordinate arousal func­
tions throughout the 
brain. Our own recent 
work has strongly 
supported Dr. Leonards 
pioneering conclusions.
These breakthroughs in 
our understanding of 
hypocretin (orexin) may have important 
applications for treatment of narcolepsy 
and also for a broad spectrum of sleep 
and arousal disorders."
"Hypocretin/orexin excites the cholinergic 
neurons," declares Dr. Leonard, "an 
unexpected finding because all the evi­
dence suggested this peptide should 
keep these neurons in check. We demon­
strated that hypocretin/ 
orexin excites these neurons 
through multiple mecha­
nisms, including the release 
of glutamate which power­
fully excites its target neu­
rons. Others had shown the 
peptide might have such 
effects. We demonstrated 
its specific actions on the 
neurons believed to be key 
to the sleep/wake process."
Orexin 
revealed
Now that some key 
actions of orexin have 
been revealed, Dr. Leonard 
is pondering the mecha­
nisms and consequences 
of these actions. In one 
study with Dr. Kohimeier, 
they are investigating why
the orexin system stimulates an 
increase in intracellular calcium, an 
element critical to controlling signal­
ing molecules, gene expression and 
excitability. He will also continue to 
follow a lead he developed with his 
associates, Chris TyleT Ph.D., and 
Sophie Burlet, Ph.D., that orexin's 
major action to incite neurons is 
achieved by opening an ion channel 
that is permeable to sodium, potas­
sium and possibly, calcium. This com­
plicated process may account for the 
excitability action on neurons.
"Understanding these details is only 
the beginning. These animals should 
allow us to test long standing 
hypotheses about the role of modula­
tory neurons in sleep and waking, 
says Dr. Leonard, "indeed, they may 
help us understand the molecular 
consequences of sleep since we can 
look for differences in gene expres­
sion in the key neural circuits control­
ling sleep in normal and narcoleptic 
animals. Moreover, if orexin is keep­
ing us awake, an antagonist might be 
useful in promoting sleep, and insom­
nia is a major clinical complaint 
related to sleep. In fact, major phar­
maceutical companies are already 
pursuing this idea" C3
guished for having shown that a loss of 
hypocretin (orexin) neurons is also the
NARCOLEPSY 10T Neurons releasing histamine, serotonin, 
noradrenalin and acetylcholine (blue and red pathways, top left) 
normally control wakefulness. These neurons (top right) are 
stimulated by the neuropeptide orexin through activation of two 
> receptors (bottom left). These receptors stimulate membrane ion
m channels and pumps (bottom right), although the underlying
■ mechanisms are not understood. Since narcolepsy results from
■ loss of orexin or its receptors, understanding these mechanisms 
B may help in developing new drug therapies.
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Pharmacology
“a realiob’
Karen Davis-Bruno, Ph.D.’91, praises integration of 
physiology and pharmacology as best preparation for
her top position.
ig Brother can come in many 
forms: the FBI, the IRS, the 
CDC and the CIA. If you’re a 
ic*medical scientist like Karen L. 
Davis-Bruno, Ph.D., ’91, add the FDA. 
Like the carvings on Mount Rushmore, 
the Food and Drug Administration 
looms over the Rockville, Md., land­
scape, an omniscient force to be reck­
oned with by every person and firm that 
seeks to market a drug, biologic or 
medical device in the U.S. Even foods 
and herbal concoctions or dietary sup­
plements that state medical claims 
must still pass FDA inspection as free 
from toxic substances. The red tape can 
be daunting, but for those who want to 
learn drug development, there is an
alternative: jump sides and join up. 
That’s what Dr. Davis-Bruno did four 
years ago, and today she is the 
Supervisory Pharmacologist, FDA/ 
CDER/OND, division of Metabolic and 
Endocrine Drug Products for the 
abbreviation-happy FDA.
The CDER stands for the Center for 
Drug Evaluation Research, where 8,000 
people work in one of the agency’s nine 
divisions; the OND refers to Office of 
New Drugs. What that lengthy title 
means is in effect, Dr. Davis-Bruno 
supervises the pharmacologists who 
are responsible for evaluating the 
safety of a new drug. The review group 
comprises a pharmacologist, clinician, 
project manager, chemist and clinical
pharmacologist. The primary reviewer 
evaluates the raw data, and based on 
integrating scientific findings with the 
health risk and the law, the group makes 
a recommendation to approve or deny. 
"It is a team decision," she says, and the 
role she plays "is a real job that truly has 
impact on drug development."
Drug development
If figuring out what she really wanted 
to do and then doing it constitutes "a 
real job," as opposed to the research 
she was doing before she got the FDA 
job, it sounds like fodder for the 
Freudian line. Remembering her 
undergraduate days at Fordham 
University in the Bronx, where she
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earned a B.S. degree in 
biology, she says. "I took 
a pretty basic course in 
introductory psychology 
during my junior year and it 
briefly mentioned pharma­
cology and how drugs work.
By the time 1 left Fordham 
1 had become very inter­
ested In learning about drug 
development."
In 1983 she went to work as 
a clinical immunology labo­
ratory technologist at 
Memorial Sloan-Kettering 
Cancer Center in Manhattan.
While she was processing 
tissue cultures of T lympho­
cytes and analyzing patient 
data, she obtained a New 
York City technologist 
trainee license. Other brief 
periods of research followed 
at NYU and NYMC, where 
she was a research associate 
in the Department of 
Medicine supervised by 
Nader G. Abraham, Ph.D., 
now a professor of pharma­
cology. That was all the cata­
lyst she needed to make up 
her mind to go for a Ph.D. degree. 
Five years later, under the tutelage 
of Michal L. Schwartzman Ph.D., pro­
fessor of pharmacology, she finished 
her thesis on the "Regulation of 
corneal cytochrome P450 arachidonate 
metabolites: endogenous mediators of 
corneal inflammation." Finally, she did 
a post-doc at the Medical University of 
South Carolina in Charleston with 
Perry V. Halushka, M.D., Ph.D., investi­
gating the structural/molecular basis 
for platelet and vascular thromboxane 
receptor heterogeneity.
Private industry
'Tm a generalist at heart," continues Dr. 
Davis-Bruno. "This makes it difficult to 
work for a major pharmaceutical com­
pany where they place you in a niche. 
So I went to work for a small biotech. 
Progenies Pharmaceuticals in Tarrytown, 
N.Y., as a staff scientist developing 
therapeutic and diagnostic agents. 
Eventually they changed research direc­
Synthroid, which recently 
received approval although 
it had been used for 
decades. Physicians were 
prescribing it despite its 
never having been submit­
ted for FDA approval.
ABOVE: If you can’t fight ’em, join ’em, insists Karen Davis-Bruno, Ph.D. ’91, who 
praises her top job with the FDA as a direct resuit of the strong faculty emphasis 
in integrating pharmacology and physiology at New York Medical College.
tions, so 1 left jin May 1996|." Her next job 
with the lerome H. Holland Laboratory 
for Biomedical Sciences of the American 
Red Cross led her to Rockville, Md. Not 
only did the position of scientist give 
her genuine experience in research and 
development of a drug—a product to 
control bleeding—but also put her in 
striking distance of the FDA.
"1 thought the products being devel­
oped would never see the light of day," 
admits Dr. Davis-Bruno. "So when 1 
heard the FDA was looking for people I 
applied. What better way to learn about 
drug development than to be a 
reviewer! They interview you for a spe­
cific division based on your qualifica­
tions, and I was placed in the division of 
Reproductive and Urologic Products." 
She moved to the metabolic and 
endocrine division in August 2000, a 
very busy place to be in the era of 
fen-phen, Fosamax, Meridia and Baycol, 
one of the newer statins. There are 
dozens of thyroid medications like
Clear
conscience
"We realize a drug will have 
a major impact and we are 
concerned about safety for 
the American public. I’m in 
the right place for sure—for 
a generalist like myself," 
she repeats. "1 know the 
basics 1 learned at New York 
Med are something 1 use 
everyday, and because of 
what my interests are, 1 
know 1 received a better 
foundation than if I had 
gone to medical school...
"I would be remiss if I didn't 
mention that the strong fac­
ulty emphasis in integrating 
pharmacology and physiol­
ogy at the College was and 
continues to be essential to 
what 1 do on a daily basis. 
Although the current emphasis in the 
scientific community is at the molecular 
level—proteomic, genomics, metabo- 
nomics—we can't lose sight of what is 
going on in the whole organism. This 
seems to reflect a paradigm shift in 
medical education that is troublesome 
to the government public health sector 
and the pharmaceutical industry in par­
ticular... While it's understood that 
research funding is generally geared to 
the molecular level and approach, it is 
imperative that the integrative effects of 
whole organism fundamental biology 
continue to be taught as the backbone 
of graduate education. Otherwise, as 
the graying of the baby-boomer work­
force reaches retirement, these skills 
may be lost.
"Dr. McGiff and his jPharmacology] fac­
ulty are dedicated and highly skilled in 
this particular training. I am indebted 
to all of them for the patience, persis­
tence and skills they contributed to my 
education." C3
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Environmental
Scientist
Spearheads Business Development 
for Malcom Pirnie, Inc.
John J. Batten III, M.RH. '93, values repeat business as the 




ohn |. Batten III, M.RH. '93, is a 
licensed wastewater treatment 
plant operator, but it’s been oh, 
so long since he's done that. Still, it is 
how he got his foot in the door 22 years 
ago at Malcolm Pirnie, Inc., White 
Plains, N.Y., ranked as the fifth leading 
"all-environmental firm" by Engineering 
News Record with revenues of $216 mil­
lion in 2001. Vice president and director
of marketing since 1994, Batten heads 
the company's business development 
program of $300 million in annual sales 
to industrial, federal and municipal 
clients. What he likes best is the firm's 
commitment to improving the environ­
ment and protecting public health. "We 
are stewards of the environment, pre­




Because Pirnie provides engij 
services for water and wastewa 
ment, solid and hazardous" 
agement, air quality, infornjatiQh r*an- 
agement technology, and performance 
enhancement consulting. Batten needs 
to be prepared to discuss any of a
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wide-range of topics with clients. 
Although his background comes from 
protecting and improving the public 
water supply, his job entails being 
conversant with clients on such dis­
parate topics as microbiology and 
environmental policies and assess­
ments, impact evaluation, ecosystems 
and regulatory agencies.
About 65 percent of Pirnie's business 
revolves around helping municipal 
agencies (city, state, county) address 
environmental issues. For decades, 
Pirnie has been integral in helping its 
largest municipal client, the New York 
City Department of Environmental 
Protection, to establish and maintain 
its water and wastewater programs. 
Pirnie also assists industrial clients in 
achieving their environmental goals, 
and has worked with such businesses as 
American Airlines, AIG Insurance and 
Con Edison, which account for 20 per­
cent of the firm's revenue, while the 
remaining 15 percent comes from fed­
eral sources—the Army Corps of 
Engineers. Navy, Air Force and the U.S. 
Environmental Protection Agency.
Clients forever
"No assignment is too small for a long­
standing client," Batten declares, waving 
in the direction of his staff of 30 who 
operate with an annual departmental 
budget of $ 12.5 million. They are among 
Pirnie's more than 1,300 employees 
working in more than 40 offices through­
out North America. "Our marketing peo­
ple are all technical professionals. They 
know the business and they're licensed 
in their areas of expertise," he says.
It turns out that one of their consistent 
clients is New York Medical College, 
which "spent $280,000 on improving 
health and safety, industrial hygiene, and 
RCRA (Resource, Conservation and 
Recovery Act] compliance in the last five 
years," he says after accessing the 
records. However in 1990, Batten found 
himself the client when he embarked on 
an M.P.H. degree in environmental sci­
ence from the Graduate School of Health 
Sciences, recently renamed the School of 
Public Health. "1 completed the 45 cred­
its in three years," he says, "two courses 
each term and one in the summer.
"1 had been curious about related sub­
jects like toxicology, epidemiology, 
indoor air quality, and the program 
helped me keep current with emerging 
issues. The scheduling of classes 
accommodated my work life and my 
pretty insane travel schedule. Besides, 
1 really enjoyed my fellow students— 
studying with doctors, nurses and 
pharmaceutical reps.
"New York Medical 
College gave me 
a quality education 
and I'm proud of my 
degree."
tive that he devotes 60 percent of his 
work time "touching" his internal and 
external clientele.
Although he travels a lot of the time, 
meeting regularly with clients and 
client managers across the country. 
Batten has a firm command of 
Pirnie's corporate marketing program.
Teaches, too
Every couple of years 
in the summer. Batten 
slips on a scholarly 
cover and becomes an 
adjunct professor of 
public health, teach­
ing PH970.26.3 or 
"Public Health and 
Water Quality." "I love 
being a guest lec­
turer," he admits. "It 
speaks to my commit­
ment to the school 
and the student 
body." Being the son 
of teachers, it proba­
bly comes naturally;
"My mother taught all 
grades in school, and my father was 
a research adviser at Brooklyn 
Polytechnic." In addition to the M.P.H., 
Batten has an AAS in applied science in 
wastewater treatment from Northern 
Virginia Community College, and a B.S. 
in environmental sciences from The 
American University in Washington, D.C.
Wonder man
Batten's dictum to develop a portfolio 
of repeat clients, which make up 80 per­
cent of the roster, is of his own making. 
"We ingratiate ourselves into their lives 
and we respond to their requests," he 
emphasizes. "We have been described 
as client-centric and client-focused and 
we are. We want clients that are looking 
for a long-term relationship built on 
trust ...I'm approaching 2 million air 
miles this year," he offers as proof posi-
ABOVE: Sophisticated traveler John J. Batten III, M.RH. '93 promotes 
the environmental services of Malcolm Pirnie, Inc., as "stewards of 
the environment, preserving the quality of life,”
It makes him responsible for enhanc­
ing the firm's image and furthering the 
corporate brand through promotional 
activities that include direction of 
Malcolm Pirnie's worldwide website 
(www.pirnie.com).
Married and the father of a young son 
and daughter. Batten is a passionate 
New Yorker and New York Yankee fan. A 
resident of Manhattan, he is a devotee 
of the American arts and crafts move­
ment, which he explains is art, pottery 
and furniture created between 1900 and 
1915. "I play squash and I like to fly fish 
in Patagonia (southern Argentina and 
Chile)," he continues. But lest anyone 
think otherwise. Batten is Malcolm 
Pirnie's engine and conscience; "1 
absolutely love working here. 1 wake up 
excited to come to work because we 
really do important things." D
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Anne McTiernan,
M.D. '89, Ph.D., M.A., 
B.A., studies exercise i 
as a deterrent to 
and colon cancer af',^H| 
the Fred Hutc^insotBP 
Cancer Research Gpmer.
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The list is pretty’long for things that used to be good for you ! and now are not (estrogen) 
and versa (olive oil). Then there 
are rfler things (caffeine) that swing 
both ways, depending on the latest 
research. For a 100 percent endorse­
ment that never wavers, this advice 
from the Fred Hutchinson Cancer 
Research Center is worth consider­
ing: "Up to 70 percent of all cancers 
could be avoided by simple lifestyle 
factors such as not smoking, eating a 
healthy diet, wearing sunscreen and 
exercising regularly.” It's that last 
item, cxcrdsiiif’ rcf’uhirly, that capti-
,^at^^n alumna of the New York 
Med^^l College School of IVledicine, 
Anne^WcTiernan, (VI,D. '89, Ph.D., 
M.A., B.A., and the Public Health 
Sciences Division of Fred 
Hutchinson, which became famous 
for pioneering the bone marrow 
transplant. Dr. IVIcTiernan is director 
of the division's Prevention Center, 
which includes a research clinic, an 
exercise testing and training center, 
and a feeding studies center. These 
help to support a multi-disciplinary 
program to reduce the incidence 
and impact of cancer. Her role, 
directing a staff of 30, revolves
around changing behaviors to reduce 
breast cancer and colon cancer, her 
interests in particular. That's where the 
exercise comes in and she has the 
results to show for it.
Breast fitness
Having published widely in major 
medical journals, Dr. McTiernan 
branched out two years ago to produce 
Breast Fitness: An Optimal Exercise and 
Health Plan for Reducing Your Risk of 
Breast Cancer, for which she was editor 
and first author. "My research focuses on 
identifying ways to prevent new or recur­
rent breast cancer and colorectal cancer 
with a particular focus on physical activ­
ity and exercise," she explains. This 
should not imply she is biased toward 
complementary techniques, however. In 
addition to being a "member" (a 
euphemism for full professor) in the pre­
vention program. Dr. McTiernan is a 
research associate professor in the 
department of epidemiology. University 
of Washington School of Public Health, 
where she earned her doctoral degree. 
Her ties to the prestigious cancer center 
in Seattle began with a primary 
care/internal medicine residency at the 
university. That was preceded by a mas­
ter’s in medical sociology from SUNY 
Buffalo and a B.A. in sociology from 
Boston University.
"Breast cancer is the most common 
invasive cancer in women," she 
informs. "Everyone knows someone 
who has it—two-thirds are older 
women and 15 percent are family 
members of other patients. Fewer peo­
ple get colon cancer, but more die 
from it. With colon cancer you can find 
early disease, a polyp, which is a pre­
cursor. All you have to do is get it out. 
There are no similar precursors with 
breast cancer, and even if a lesion is 
negative, you have to go through all 
the tests and biopsy anyway."
Principal
investigator
Dr. McTiernan is principal investigator 
of several clinical trial and cohort stud­
ies that investigate the associations 
among exercise, diet, body weight, 
hormones and risk for cancer incidence 
and prognosis. Coincidentally she has
worked closely with William H. 
Frishman, M.D., the Barbara and 
William Rosenthal Professor and Chair 
of Medicine at the College, who is co­
investigator for the Women’s Health 
Initiative (WHI) study. Not only is Dr. 
McTiernan a co-investigator, but she 
also directs the clinical outcomes 
efforts at the WHI Clinical 
Coordinating Center at Hutchinson, 
one of 40 centers participating in the
trial nationwide that involves an 
astounding number of women—more 
than 165,000. Dr. McTiernan says she 
was not surprised when, picking up a 
newspaper while in Europe, she read 
that the NIH had recommended that 
subjects who were taking Prempro 
(estrogen and progestin) dr Premarin 
(estrogen alone) stop doing so and 
ended the study—one of four compris­
ing the entire WHI clinical trial.
Risks outweigh 
benefit
This hormone replacement therapy 
study, scheduled to run until 2005, 
involved more than 26,000 women, ages 
50 to 70, and was designed to deter­
mine whether estrogen plus progestin 
could prevent heart disease and hip
fractures in the subjects. A review of 
preliminary data not only showed no 
heart benefit, but also evinced a 29 per­
cent increase in heart attacks and a 22 
percent increase in total cardiovascular 
disease among women receiving hor­
mones. Equally disturbing was a 26 per­
cent increase in breast cancer in women 
taking the hormones compared with 
those on a placebo. The firestorm that 
erupted in the general population—
between gynecologists who disagreed 
with the abrupt cessation, and women 
who panicked at having to go off their 
hormones—has not waned.
"Our safety board met every six months 
and the regulations spelled out when 
the criteria for stopping was met. We 
saw an increased risk of heart attack and 
stroke early on," says Dr. McTiernan, 
"and we notified our subjects but did 
not stop the trial. We thought the indi­
cations might be temporary—but they 
were not." At any rate, the women who 
were not taking one type of hormones 
(estrogen plus progestin) are still being 
followed until the end date. They 
include those taking estrogen alone, a 
number on low fat diets, others getting 
calcium and vitamin D, and still others 
just being observed.
ABOVE: Anne McTiernan, M.D. ’89, Ph.D., M.A., B.A., does only research at the Fred Hutchinson 
Cancer Research Center, where she directs the Public Health Sciences Division Prevention Center. 
Her secret ingredient is exercise.
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Impact of research
Dr. McTiernan, who says she spends all 
of her time in research, is involved in 
several other trials. "Physical Activity for 
Total Heart (PATH)" is in its fifth year, 
funded by the National Cancer Institute 
for $3.5 million. Half of the 173 post­
menopausal subjects were randomly 
assigned to a group that exercised 45 
minutes a day, 5 times a week, primarily 
with the treadmill and bicycle. "We 
found that exercise lowered the levels 
of blood estrogens by as much as 20 
percent," she says. The study also mea­
sured cardiopulmonary fitness by hav­
ing treadmill users breathe into a 
device that separates and measures the 
gasses exhaled. Exercise increased their
Breast
Htaess
FOUNDER’S DINNER IS 
PRESCRIPTION FOR A GOOD TIME
ABOVE; This merry lineup from the New York Medical College Founder's Dinner, held at 
the Rye Town Hilton in October, featured, from left. Rev. Msgr. Harry C. Barrett, D.Min., 
M.P.H., president and chief executive officer; Alvin I. Goodman, M.D., professor of medi­
cine and recipient of the Distinguished Service Award; Barbara Z. Monohan, board chair, 
and Theodore N. Keltz, M.D., president, American Heart Association, Westchester 
Region, recipient of the Jackson E. Spears Community Service Award; Ralph A.
O’Connell, M.D., provost and dean of the School of Medicine; and Gerald Cunningham, 
member of the Board of Trustees who received the William Cullen Bryant Award,
An Optimal Exercise, and 
Health Plan for Redncing 
Yonr Risk of Breast Cancer
Anne McTiernan, M.D., Ph.D., 
Julie 6ralow. M.D. & Lisa Talbott
V02MAX, which measures the heart’s 
ability to pump blood and the lungs’ 
ability to retrieve oxygen from the 
blood, by 13 percent; controls showed 
no change. "We're also doing other clin­
ical studies and cohort studies that 
measure things like diet, weight, physi­
cal activity, blood hormones and the 
risk of occurrence and survival," says Dr. 
McTiernan. "And we are storing blood 
that can be used in research for any 
disease." Though menopause is not an 
ailment, it certainly leaves a large per­
centage of women with very uncomfort­
able symptoms. The doctor's research 
team might consider looking into 
something to take the place of the 
estrogen/progestin solution that turned 
out to be no panacea. C3
ABOVE: Msgr. Barrett, left, was touched by the surprise citation he received from Dean 
O’Connell to commemorate his first decade of inspired leadership. C3
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GERARD P. CURRAN, M.D. ’95 AND PHILIP HIRSHMAN, M.D. ’94
Working in the Middle East,
as Doctors and Soldiers
Gerard R Curran,
M.D. ’95, and Philip 
Hirshman, M.D. '94, 
shared a dream: to 
become doctors and 
soldiers, to care for 
people and to serve 
their country. Although 
they’ve never met, 
they followed their 
dream down a similar 
path—from the mili­
tary to medical school 
to active duty, includ­
ing tours in the Middle 
East, where they sup­
ported the U.S. in its 
efforts against 
Afghanistan. Recently 
discharged, both have 
returned to family, 
with a new appreciation 
for home.
They were soldiers first. Dr. 
Curran, 38, an emergency 
medicine physician who grad­
uated from West Point Military 
Academy in 1986, said med­
ical school was always in the 
back of his mind. At the 
beginning of the Gulf War, 
while awaiting deployment to
Dr. Gerard Curran gives tender care to one of his younger patients.
Kuwait, he applied. “I was up 
all night doing guard duty, and 
I filled out an application to 
New York Medical College,” 
says Dr. Curran, formerly a 
major in the U.S. Army. When 
he returned six months later in 
April 1991, he had invitations 
to interview at four medical 
schools. New York Medical 
College was the lucky winner.
Dr. Philip Hirshman stops for a picture while in flight aboard a 
C-130 military transport piane over Afghanistan, en route to a 
U.S. military hospital in Uzbekistan.
Dr. Hirshman, an obstetrician/ 
gynecologist and also a former 
Army major, joined the ROTC in 
college and spent those four 
years of reserve duty—half of 
his eight-year obligation to the 
Army—attending NYMC. After 
his residency, he was assigned 
to Fort Hood, Texas, which he 
calls “the busiest obstetrical 
service in the Department of 
Defense.” Coining himself a 
“combat gynecologist,” he 
treated the wives and children 
of 42,000 active duty troops, 
plus retirees. “That’s a lot of 
people,” Dr. Hirshman says.
Dr. Curran also treated a large 
patient population, as an 
attending emergency room 
physician at Fort Bragg, S.C. 
Home of the 82"“ Airborne 
Division, Fort Bragg has an 
emergency department that 
handles 70,000-75,000 patients 
a year, many with intercranial 
bleeds and broken backs or 
pelvises from jumping out of
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SHEILA CONKLIN, M.P.H.
Making Health Care Connect
i
i
Among the many complaints about health care today, 
lack of continuity ranks high.
Managed care, in its efforts 
to contain costs, has made 
patients, even those with mul­
tiple medical needs, their own 
case managers. They must 
choose their own specialists 
from a list of referred 
providers and schedule their 
own appointments.
Frequently they must 
spend time and money 
traveling to distant 
medical offices. While 
this may save health 
plans money, it exacts 
a price from patients in 
increased stress, lost 
income and time that 
could be devoted to 
their care. Sheila 
Conklin, M.RH. '00, 
would like to change 
that.
“It’s overwhelming to 
deal with diagnoses,’’ 
says Conklin, who 
earned her degree in 
health policy and man­
agement at New York 
Medical pollege. “A 
patient with cancer doesn’t 
want to wait for an appoint­
ment or an answer. It’s nerve 
wracking.’’
Conklin, who works for the 
Office of Clinical Practice 
Evaluation at New York- 
Presbyterian Hospital in 
Manhattan, is interested in 
changing the way health care 
is delivered. And she plays a 
significant role in improving 
the delivery of care at the 
medical center. As manager of 
clinical information support, 
Conklin gathers data to show 
administrators how effectively 
the hospital is integrating 
patient care through "service 
lines,” its system for linking all 
providers, treatments and ser­
vices related to a particular 
disease. For example, the 
oncology service line makes
sure surgeons, oncologists, 
radiologists and even physical 
therapists are communicating 
and working together to coor­
dinate a patient’s care. “It’s 
continuous care we’re looking 
for within the disease 
process," Conklin says.
Integrating patient care is 
important from a patient, as 
weli as a business, perspec­
tive, says Conklin, who has an 
MBA in healthcare finance. 
“Integrated care is something 
you can market,’’ she says. 
“Patients don’t want to go 
searching for doctors or sec­
ond opinions. They’d rather 
have a place that handles all 
aspects of care under one 
umbrella. It’s like having a 
general contractor for your 
house.”
Health care—the clinical and 
the business side—has 
always attracted Conklin.
While weighing a career in 
medicine as an undergradu­
ate at Boston University, she 
began working part-time as a 
medical transcriber at Boston 
Medical Center. Her increas­
ing interest in healthcare 
finance and management pro­
pelled her to earn a master’s 
degree in business adminis­
tration. She worked in banking 
for a whiie and then became a 
financial analyst in the interna­
tional division of Bristol-Myers
Squibb. After staying home to 
raise her two children, Conklin 
decided to return to health­
care finance, but first wanted 
to earn a public health degree. 
“I knew it was going to take 
some education to get my 
credentials up to speed," she 
says.
Less than a year after gradu­
ating from NYMC, Conklin par­
layed her background in med­
ical records, physiology and 
biology, finance and public 
health into her current job. Still 
drawn to the clinical aspects 
of care, she eventually would 
like to manage an entire oper­
ating area, where treatments 
are administered and she can 
interact with patients. But for 
the time being, she says, “I 
know what I’m doing is mak­
ing a contribution.” ♦
Sheila Conklin, M.P.H. '00
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_ Anatomy of a
Romance
Neither Alissa Bennett, M.D.
’02, nor David Hersh, M.D. '02, 
was looking for love, especially 
in their first year of medical 
school. But from the moment 
they met, they knew there would 
be something between them. 
And they knew what that some­
thing would be: a cadaver.
ing her early relationship with 
David. In fact, the two hardly 
spoke to each other, which was 
neither here nor there, since 
David was casually dating 
other people and Alissa had a 
boyfriend at the time. But by 
the end of that first semester, 
things began to change.
“The first time we met we were 
looking at the bulletin board to 
see who our anatomy lab part­
ners were," says Alissa, now 
Alissa Hersh, who married 
David two Thanksgivings ago. 
They didn’t see each other 
again until a week-and-a-half 
after orientation, standing 
around the anatomy table with 
two other first-year students, 
Ruth Alejandro and Nicole 
Lanatra. “We weren’t really 
friends,” Alissa says, describ-
13
Is There a Spouse i 
in the House?
Alissa and David Hersh’s 
meeting and marriage may 
sound iike romantic coinci­
dence. Consider, however, 
they are among five cou- 
pies from the Ciass of 2002 
who have married. Trend 
hounds couid have a field 
day with the number of 
matrimonial knots tied—or 
being tied—in the Ciass of 
2002. But according to 
Aiissa Hersh, there is realiy 
no great mystery as to why 
med students marry each 
other. “We don’t have time 
to see anybody else,” she 
says, only half-kidding. In 
fact sharing the stress of 
medical school is actuaily 
what brings many couples 
together, she says. Other 
members of her class who 
married (as of October 1) 
are Bhriju Chopra and 
Reena Maihotra; Anupam 
(Bobby) Garg and Biraj 
Shah; Eun Ha Kim and 
David Shin; and Anne- 
Marie Mays and Ciayton 
McDaniel.
Call it chemistry, call it coinci­
dence, or kismet. When you’re 
a first-year medical student, 
finding the person you know 
you want to share the rest of 
your life with could easily take 
all three. For David and Alissa, 
sharing the same kind of hec­
tic and demanding schedule 
actually helped set the stage 
for the relationship. “We saw 
each other every day,” recalls 
Alissa, who says she felt her 
first romantic inkling toward 
David when he brought her a 
Diet Coke and a Snickers bar 
in the library and then walked 
her back to her apartment at 2 
a.m. “I thought, ‘Wow, that was 
really very nice,"’ she says.
“He got big points for that.”
From then on, the couple 
spent a “crazy amount of time 
together,” studying, sharing 
meals and walking together to 
class. “We really got to know 
each other,” she says. As 
nature took its course, they 
discovered that their fathers, 
Sheldon Hersh, M.D. ‘78, an 
otolaryngologist, and the late 
Harold Bennett, M.D. ‘62, an 
orthopaedic surgeon, had 
both graduated from New 
York Medical College.
While a year-long courtship 
may sound brief, if not down­
right rushed, in this age of pro­
longed engagements, sharing 
the rigor and stress of medical 
school, getting acquainted in 
the most difficult of times— 
and falling in love despite 
them—assured David and 
Alissa that they were meant 
for each other. “You have the 
opportunity to get close,”
David Hersh, M.D. ’02 and Alissa Bennett Hersh, M.D. '02, 
once anatomy lab partners, are now husband and wife.
Alissa says. “You share a lot of 
stresses and bonds. You get to 
know that person in a stressful 
circumstance and see how they 
react in different situations.”
Not that the evolving romance 
didn’t take them by surprise. 
The demands of medical 
school alone seemed to elimi­
nate any possibility of having 
a serious relationship, David 
says. A soft-spoken man 
whose few words come out in 
rapid fire, he says, “Dating 
someone [seriously] at that 
point was the last thing I had 
on my mind.” When he did 
envision settling down, it cer­
tainly wasn’t with a doctor.
“He wanted someone who 
had a 9 to 5 job, which would 
allow her to be home by 6 or 7 
at night,” says Alissa, who 
admits she wasn’t looking for 
marriage either. “I didn’t have 
any vision of being married,” 
she says in a bubbly voice, a 
stark contrast to her husband’s 
matter-of'factness. “I thought 
medicine was going to be the 
first thing to ground me and 
then marriage. It turned out to 
be the other way around.”
David, an Orthodox Jew, 
explains that tradition does 
not condone dating indefi­
nitely. He proposed in March 
of their second year of med­
ical school. On the Sunday 
after Thanksgiving—Novem­
ber 26, 2000—they married. 
“We had finished our family 
medicine rotation on Wednes­
day,” Aiissa says. “Thursday
was Thanksgiving. Monday 
was the first day of our neu­
rology rotation.” On Monday 
they honeymooned. On 
Tuesday they were back in 
school.
Today, just past their second 
wedding anniversary and only 
six months out of medical 
school, the Hershes are learn­
ing to balance their lives as 
new doctors—and spouses. It 
is a challenge, especially with 
schedules that have them 
passing like ships in the night, 
one going to and the other 
returning from the hospital. 
While David, an internal medi­
cine intern at Lenox Hill 
Hospital in Manhattan, worked 
from 9 p.m. to 7 a.m., six days 
a week during the summer, 
Alissa, a pediatric intern at 
Montefiore Medical Center in 
the Bronx, worked from 6:45 
a.m to 5:30 p.m., six days a 
week. “We saw each other 
for a couple of hours in the 
middle,” David says.
Such a schedule would stress 
the most solid couples, but 
the Hershes are learning to 
work it out. “Just living with 
somebody totally changes 
your understanding of the 
other person. You adjust your 
expectations in order to help 
each other,” Alissa says.
“We both have our separate 
lives during the day and 
appreciate what the other is 
going through. The time we 
do have together we try and 
make special.” ♦
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The Founder’s Dinner
Honoring New York 
Medical College 
and Its Supporters
New York Medical College 
paid tribute to its staunchest 
friends and supporters at the 
annual Founder’s Dinner held 
in October at the Rye Town 
Hilton in Rye Brook, N.Y The 
College paid tribute to Gerald 
W. Cunningham, president 
and chief executive officer of 
Glenties Leasing and a mem­
ber of the College Board of 
Trustees; Alvin I. Goodman, 
M.D., professor of medicine, 
and the American Heart 
Association Westchester 
Region for years of friendship 
and service. It also specially 
recognized Rev. Msgr Harry C. 
Barrett, D.Min., M.RH., president 
and chief executive officer, for 
his decade of leadership.
A trustee for more than 13 
years, Cunningham received
I
the William Cullen Bryant 
Award, named for the College’s 
founder, in honor of his leader­
ship, business expertise, loyalty 
and generosity. Dr. Goodman, 
retired director of the Division 
of Nephrology and current 
director of the Westchester 
Artificial Kidney Foundation, 
received the Distinguished 
Service Award for more than 
30 years of service. The heart 
association received the 
Jackson E. Spears Community 
Service Award for the educa­
tion, research and advocacy 
it has dedicated to fighting 
heart disease.
In his opening remarks. Rev. 
Barrett said, “The individuals 
whom we honor tonight exem­
plify the best of New York 
Medical College.” In addition
Enjoying the evening were, at left, Kevin Reilly, M.D., 
director of obgyn at Our Lady of Mercy Medical Center in the Bronx; 
his wife, Marcelle Reilly, and at right, Elliott N. Perla, M.D. 74, 
chief of the department of medicine at Metropolitan Hospital 
Center, and his wife. Heather Lurie, M.D.
Old and new friends gathered at the Founder's Dinner including 
from left, Joseph F. Dursi, M.D. '59, associate professor of surgery 
Joseph P. Corcoran, president of The New York Eye and Ear Infirmary; 
James J. Walsh, M.D. '80, chairman of the Department of 
Ophthalmology; Louis E. Fierro, M.D. '60, president of the 
Alumni Association; and William H. Frishman, M.D., Barbara and 
William Rosenthal Professor and Chair of Medicine.
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to applauding their achieve­
ments and contributions, 
the dinner also serves as the 
College’s major fundraising 
gala, raising significant dollars 
in support of its educational 
and research activities.
Saverio Bentivegna, M.D. ’50, 
senior associate dean, echoed 
many alumni when he said the 
evening filled him with pride: 
“I’ve seen the College develop 
into what we dreamed of 25 
years ago, when we moved 
from New York City to West­
chester. It is a first-class med­
ical university that makes its 
alumni proud.” Elliott Perla,
M.D. ’74, chief of the depart­
ment of medicine at Metropoli­
tan Hospital Center, praised 
the College for having more 
diversity, talent, research, and 
resources than ever “The 
school has grown so much in 
the 30 years since I matricu­
lated it’s amazing,” he said.
Richard Stone, M.D. ’68, 
senior associate dean at 
Metropolitan Hospital Center, 
said the hospital—a teaching 
and training facility for NYMC
residents—like the College, 
had seen dramatic growth. 
“When I trained at Metropoli­
tan as a junior medical 
student, it was a massive, 
chaotic 1200-bed hospital. It 
looked like the IRT station at 
rush hour Now it’s a 341-bed, 
recently renovated, state-of- 
the-art facility,” he said.
While saluting the College, 
alumni also enjoyed the 
opportunity to catch up with 
colleagues and friends. Gene 
Cayten, M.D. ’67, professor of 
surgery at NYMC and pro­
gram director for the depart­
ment of surgery at Our Lady 
of Mercy Medical Center in 
the Bronx, said, “It’s nice to 
see the College grow and 
expand and to renew acquain­
tances." Cono Grasso, M.D. 
’74, who also came to see old 
friends, said he felt proud to 
be on the faculty of his former 
medical school. Chairman of 
the department of ophthalmol­
ogy at Saint Vincent Catholic 
Medical Centers, and assis­
tant professor of ophthalmol­
ogy at the College, Dr. Grasso 
said he is especially pleased
Alumni
Honored at the Founder’s Dinner for dedicated service were, 
from left, Alvin I. Goodman, M.D., recipient of the Distinguished 
Service Award, and Trustee Gerald W. Cunningham, who received the 
William Cullen Bryant Award in honor of his leadership, business 
expertise, loyalty and generosity.
Toasting the College are representatives of the American Heart 
Association (AHA) Westchester Region, honored for years of friendship 
and service. From left are, Barbara Z. Monohan, board chair of 
the AHA Westchester Region; Theodore N. Keltz, M.D., president 
of the board; and Shelley Letter, AHA executive director.
MILESTONES
2002
Brendan J. Bligh, M.D. ’02, has begun 
a three-year residency in family practice 
at St. Joseph’s Medicai Center in 
Yonkers, N.Y,
Michelle L. Brosnan, M.D. ’02, received 
a $1,000 fellowship from the BPW/NY 
Grace LeGendre Endowment Fund on 
June 8, 2002. Named for a former 
president of Rochester Business and 
Professional Women's Clubs of New 
York State, the fund provides fellowships 
annually to women enrolled in graduate 
programs in New York State and who 
are state residents. Dr. Brosnan, an 
emergency medicine physician, will 
spend her first year of residency at 
St. Vincent’s Hospital in Manhattan.
David L. Fernandes, M.D. ’02, Is an 
internal medicine resident at the University 
of Southern California hospitals in Los 
Angeles. His mother is Elaine Dlgrande- 
Fernandes, M.D.’67.
Heather Goff, M.D. ’02, Is doing her 
four-year residency program in psychia­
try at Yale-New Haven Hospital in 
New Haven, Conn,
Gall Clifford, M.D. ’91, is working as a 
full-time hospitalist at Southwest Iowa 
Medical Center in Council Bluffs, Iowa. 
(A hospitalist cares for hospitalized 
patients and does not maintain a private 
practice.)
Shevaun M. Doyle, M.D. ’92, is a pediatric 
orthopaedic surgeon with Westchester 
Orthopaedic Associates, PC in White 
Plains, N.Y.
Daniel J. Glatt, M.D. ’92, is practicing 
internal and addiction medicine in South 
San Francisco with his father, William 
Glatt, '64. He is the father of two, Taylor 
Rose and Evan.
Sandy S. Rich, M.D. ’92, is married 
to Judith D'Ariano, sister of Gerard 
D’Ariano, M.D. ’92, and has three 
wonderful children. He completed his 
hematology/oncology fellowship at Yale 
and is practicing in the Chicago area.
Joheph E. Chase, M.D. ’93, graduated in 
July from the San Francisco Orthopaedic 
Ftesidency Program at St. Mary’s 
Medical Center, where he completed his 
residency in orthopaedic surgery. He is 
beginning a fellowship at Massachusetts 
General Hospital in Boston. He will be
to be working with NYMC 
graduates who comprise 20 
percent of the residents he 
supervises. “They’re extraordi­
narily well-trained,’’ he said.
That many alumni have 
decided to return as faculty 
members is a testament to the 
College’s superior education 
and training, said Leonard 
Newman, M.D. '70, chairman 
of the Department of 
Pediatrics. Dr. Newman, who 
recently received his 30-year 
pin, beamed with joy when he 
mentioned that his daughter, 
Rebecca, is a second-year 
student. He knows firsthand
that she is getting a superb 
medical education, he said. 
Mary Hawkins, M.D. ’75, 
remarked it was her education 
at NYMC that allowed her to 
enjoy learning for the first 
time. “Being at the medical 
college was the first time I 
wanted to learn for the sake 
of learning," she said.
The evening was more than a 
tribute to achievements in edu­
cation, training and research 
at the College, According to 
Philip Marraccini, M.D. '50, a 
member of the Board of Trustees, 
“It is a tribute to what we are 
going to do in the future!" ♦
2001
Michael Schuster, M.S. '01, is working 
for Angioblast Systems, a company 
seeking a cure for heart disease using 
adult stem cells.
1990s
Paul Antonecchia, M.D. ’90, has been 
appointed to the board of tmstees of St. 
Vincent’s College in Bridgeport, Conn, He 
is medical director of informatics in the 
quality management department of St. 
Vincent’s Medical Center and chairman 
of the St, Vincent’s physician clinical 
information system task force. Board- 
certified in internal medicine, he is also 
an assistanLclinical professor of medi­
cine at both Columbia University and 
New York Medical College.
John Ragan, M.D. ’90, has joined the 
staff of the Dakota Clinic in Fargo, N.D. 
Dr. Ragan, an invasive cardiologist, will 
be working in the clinic’s heart and 
vascular center.
Tamara A. Topoleski, M.D. ’90, is 
practicing at the Orlando Orthopaedic 
Center in Fiorida, where she specializes 
in general orthopaedics and pediatric 
orthopaedic surgery. She is also affili­
ated with Florida Hospital and Orlando 
Regional Healthcare.
involved in the care of high school, 
collegiate, and professional sports teams, 
including the New England ftevolution, 
the New England Patriots, and the 
Boston Bmins.
Carri Allen Jones, M.D. ’93, has become 
a full partner with Orthopedic Associates 
of Central New York, in Syracuse.
Michael Murray, M.D. ’93, finished his 
residency in orthopaedics at Westchester 
Medical Center and will be doing a 
fellowship at the University of California, 
San Francisco.
Philip Hirshman, M.D. ’94, a doctor 
with the U.S. Army, recently returned 
from deployment to Southwest Asia and 
the Middle East, in support of Operation 
Enduring Freedom. He is happy to be 
back home with his wife and two children. 
His military commitment over, he plans 
to go into private practice in Dallas, Texas.
Robert V. Steinberg, M.D. ’94, has
joined the department of medicine at 
Arden Hill Hospital/Horton Medical 
Center in Middletown, N.Y. He is also 
affiliated with Mid-Hudson Hematology/ 
Oncology in Middletown.
Barbara Ruth Bellar, M.D. ’95, a family 
practice physician, is also a captain in 
the U.S. Army Fteserve and a lawyer. In 
June she received her Juris Doctor from 
John Marshall Law School in Chicago.
continued on page 33
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Bringing OF ANATOMY
The students file in, one by 
one. It is their first year of 
medical school and Day One 
of Gross Anatomy Lab. They 
are excited and tentative. 
Mostly they are eager to learn 
about the human body in a 
room \A/here spaciousness, 
fresh air, hanging plants and 
natural light bring a sense of 
humanity to the study of 
anatomy. Opened last fall, the
state-of-the-art facility has 
taken anatomy class from dark-, 
ness to light and raised its 
academic, research and train­
ing capabilities for students 
and doctors to new heights.
“The gross anatomy lab is the 
showcase of the Medical Edu­
cation Center," says Joseph 
Etiinger, Ph.D., professor and 
chairman of the Department 
of Cell Biology and Anatomy.
“It is probably the most spec­
tacular facility of its type in 
the country.” Witness the dra­
matic increase in the number 
of new medical students who 
had multiple acceptances to 
other schools. Dr. Etiinger 
says. “This year, 46 percent of 
the College’s new medical 
students—versus 27 percent 
last year—had multiple 
acceptances to other schools. 
In my opinion this is due pri­
marily to the Medical Educa­
tion Center and, in particular, 
to the impression that the new 
gross anatomy lab makes on 
applicants during their cam­
pus tour. After all, many stu­
dents have some initial anxiety 
about anatomy.”
James Wyss says the new lab 
was a big deciding factor in 
choosing a medical school. 
“Almost all the other ones I saw
were in a basement,” says the 
first-year student. “The cadav­
ers are gloomy enough, and 
then to be in a dark basement 
—it’s like life and death.” Katie 
Llewellyn, who also had several 
offers, says the lab was another 
plus for NYMC: “It made my 
decision easier.” Teviah Sachs 
appreciates the respect and 
humanity the new lab brings to 
anatomy. “It seems more 
respectful to have the cadav­
ers in a nice place,” he says.
Catherine Halkett, M.RH., 
vice president for university 
development, says the gross 
anatomy lab is a limitless tool, 
multiplying the possibilities of 
what the College’s students, 
researchers and clinicians 
can learn and accomplish. 
“This lab will have a lifelong 
learning function, not only for 
new students but for the con­
tinuum of being a physician.”
The $2 million laboratory, a gift 
from the Alumni Association of 
the School of Medicine, occu­
pies the entire top floor of the 
Medical Education Center. Its 
high ceilings and clerestory— 
the skylight-like windows that 
span the entire length of the 
room—give the room airiness, 
flooding it with ambient, nat­
ural light. What makes the lab 
especially pleasing to work in 
is its specialized ventilation 
system, which infuses the 
room with fresh air 18 times 
an hour. The 2,800 square feet 
provide 28 percent more 
teaching space than the old 
lab, and it can accommodate 
up to 36 dissecting tables, 
allowing for the study of 75 
cadavers—compared to 50 in 
the old lab—at a time.
Students and teachers agree 
that the lab enhances learning 
and teaching. “It was difficult 
coming in here,” says 
Matthew A. Pravetz, C.RM., 
Ph.D. ’88, associate professor 
and gross anatomy course 
director. “When we didn’t have 
any light coming into the room 
you had little idea of how time 
was passing.” Students had 
no sense of class work dead­
lines. Their minds wandered.
Dana Grasso, a second-year 
student, insists, “The old lab 
was depressing.” Dr. Pravetz 
says it made even his energy 
lag. But in the new sun-filled 
room, concentration and focus 
are better. “I am more ener­
gized,” he says.
Jon Perrillo, M.D. ’00, a third- 
year general surgery resident 
at Westchester Medical 
Center who attends monthly 
anatomy reviews there, admits 
he just feels happier in the 
new lab: “It puts me in a better 
frame of mind.”
Dr. Etiinger credits the lab’s 
innovative design for totally 
changing the teaching atmos­
phere. “A single large open 
space encourages comradery
The new Alumni Gross Anatomy Laboratory is bigger and brighter 
than the old lab, equipped with more teaching space, 
fresh air, natural light and hanging plants.
^ Annual Fund 
To Help Alumni 
Association Pay 
For Lab
The new Alumni Gross 
Anatomy Laboratory was 
made possible through a 
gift of the New York 
Medical College Alumni 
Association. The associa­
tion has already raised half 
of the $2 million it pledged 
to fund the lab, but accord­
ing to Catherine Halkett,
M.P.H., vice president for 
university development,
“The need is still great.”
This year's alumni annual 
fund is again earmarked 
for the lab. Louis E. Fierro, 
M.D. ’60, president of the 
Alumni Association, is 
appealing to all alumni— 
including those who have 
already contributed—^to 
help fulfill the association’s 
pledge. “It is essential that i 
we complete this pledge
I
 that binds us all together.
Your contribution is criti­
cally important to us,” Dr.
Fierro said.
among the entire class,” he 
says. When needed, portable, 
soundproof walls can recon­
figure the space into four or 
five different modules. “This 
way we can have different 
things going on at the same 
time,” Dr. Pravetz says. Digital 
cameras, video monitors and 
speakers enable students 
throughout the room to observe 
a procedure at one table. The 
lab has separate changing 
areas with showers and lockers 
for students and faculty, as well 
as cold and warm rooms, and 
embalming rooms, x-ray light 
boxes, dry boards for teaching 
and presentations and hands­
free sinks for washing and 
rinsing anatomic specimens. 
There is also a faculty office, 
teaching preparation areas, and 
extensive storage space for 




« Victor Altchek, M.D. ’42
Assumes Leadership 
of Medical Dynasty
Victor Altchek, M.D. '42
Ask Victor Altchek, M.D. ’42, 
about himself and he’ll change 
the subject. He would rather 
talk about his family, His chil­
dren (his son’s a doctor), 
seven brothers and sisters, 
(two brothers became doc­
tors) and at least ten nephews 
and nieces (all doctors) fill 
him with pride. But his great­
est admiration is for his late 
brother, Salvator Altchek, M.D. 
’34, who died in September. 
Revered as a great humanitar­
ian, Salvator treated all people, 
especially the poor, for as little 
as $5 and often for nothing. 
Victor doesn’t mention that he 
has followed in his brother’s 
footsteps.
their children, “tzedakah” 
(good deeds) was supreme. It 
inspired Emanuel Altchek, M.D. 
’26, to pay Salvator’s tuition to 
medical school, and for Sal­
vator to pay Victor’s in turn.
Doing good deeds has been 
a constant theme in Dr. 
Altchek’s life. “We weren’t 
interested in finance. We were 
interested in helping people,” 
Dr. Altchek says. His son, 
Douglas Altchek, M.D., a New 
York City dermatologist, says 
his father has been a great 
humanitarian. “My father oper­
ated on numerous people 
throughout his long surgical 
career for no money. He would 
go in the middle of the night 
to the hospital to perform 
emergency operations, often 
without getting paid," he says. 
When a small plane hit the 
Empire State Building in 1945, 
Dr. Altchek—an intern at the 
time—grabbed an emergency 
kit and went to the most dev­
astated floor in an attempt to 
help the wounded. The kit 
turned out to be an obstetrical 
kit. Nevertheless, Dr. Altchek 
improvised, beginning an 
impressive career in general 
surgery.
A retired general surgeon. Dr. 
Altchek was born in 1919 in 
New York City where he lived 
with his family on Fifth Avenue 
and 110“’ Street. The youngest 
of eight, he was one of three 
Altchek children to become a 
doctor and the third to attend 
New York Medical College. 
(Two of his nephews and one 
great-nephew also attended 
NYMC: David Shapiro, M.D.
’71, Edgar Altchek, M.D. ’66 
and Martin Altchek, M.D. ’49). 
His parents, Rachel and 
David, were poor, hardworking 
Sephardic Jews from Salonika, 
Greece, who immigrated to 
New York in 1914. Among the 
many values they instilled in
“My father was always a mas­
ter technician and always able 
to do operations with lightning 
speed and accuracy,"
Douglas Altchek says. “He 
could do a thyroidectomy in 
15 minutes, a gall bladder in 
an hour, and a colon section 
in an hour. I never saw any­
body who could operate with 
as much speed and precision 
as my father.” After graduating 
from New York Medical College, 
Victor Altchek did his resi­
dency at Beth Israel Hospital 
in Manhattan. He also trained 
at Bellevue Hospital in pedi­
atric surgery. In 1954 he 
joined an HMO, the Queens
MILESTONES
Glenn E. Bulan, M.D. '95, has joined 
the staff at Eye Health Vision Centers 
in North Dartmouth, Mass. Dr. Bulan 
specializes in pediatric ophthalmology 
and adult strabismus. Me is clinical 
assistant professor in the department 
of ophthalmology at Brown Medical 
School in Providence, R.l. He also has 
appointments at Rhode Island Hospital/ 
Hasbro Children's Hospital, Women and 
Infants Hospital and Kent County Hospital.
Gerard P. Curran, M.D. '95, a former 
major/doctor in the U.S. Army, just 
completed a six-month tour of duty in 
Afghanistan/Uzbekistan where he was 
based primarily at Bagram. During his 
deployment and enroute to Womack 
Army Hospital his wife, Lara, gave birth 
to their second son, Luke.
Lawrence J. Fliegelman, M.D. '95, 
completed a fellowship in facial plastic 
and reconstructive surgery in June 
2001. Specializing in otolaryngology, he 
is in private practice in Fairfield, Conn. 
He is also an attending physician at 
St. Vincent's Hospital in Bridgeport 
and at Bridgeport Hospital. In error,
Dr. Fliegelman was listed as a graduate 
of the class of '90 and employed at 
St. Vincent's Hospital in New York City 
in the last issue of Chironian.
Lisa Forman, M.D. '95, completed her 
residency at Mt. Sinai Hospital in New 
York City and is an attending pediatrician/ 
emergency room physician at Elmhurst 
Hospital in Queens, N.Y.
Eugene Spagnuolo, M.D. ‘95, has
joined the department of emergency 
medicine at Horton Medical Center in 
Middletown, N.Y.
Ajay Bajwa, M.D. '96, has joined the 
staff of Gaston Memorial Hospital in 
Gastonia, N.C. He is a cardiologist with 
The Sanger Clinic in Gastonia.
Efrat (Effie) Lobel, M.D. '96, is an
attending physician in gastroenterology 
at Kaiser Permanente in Woodland Hills, 
Calif She is married to Richard Katz and
is mother to one-year-old Michael.
Kevin P. Sullivan, M.D. '96, has joined 
the medical staff of feirlawn Rehabilitation 
Hospital in Worcester, Mass. Dr. Sullivan 
is a physical medicine and rehabilitation 
physician specializing in spine problems. 
He also practices physiatry with The 
Boston Spine Group at the New England 
Baptist Hospital.
Dale F. Wilson, M.D. '96, Is the proud 
mother of Nicole Barbara Sasso, who 
was bom September 11,2001 at 4:55 
a.m. Dr. Wilson is married to Philip 
John Sasso, M.D.
Rena R. Fromowitz, M.D. '97, completed 
her medical-pediatric residency at 
University Hospital and Medical Center 
at Stonybrook in 2001 and has been 
in private practice with Crystal Run 
Healthcare in Orange County, N.Y. She 
practices internal and pediatric medicine 
and lives in Monroe, N.Y. with her hus­
band and two-year-old daughter, Ariella.
Mary Grace Pagaduan, M.P.H. '97, is
working as a family support specialist for 
the American Red Cross, helping families 
of victims killed in the September 11 
attacks on the World Trade Center. She 
Is based in New Canaan, Conn.
Bryan Hauser, M.D. '98, a family practice 
physician, has joined the medical group 
of Dartmouth-Hitchcock in Jaffrey, N.H.
Yu-Fang Lin, M.D. '98, has joined the 
departments of pediatrics and medicine 
at Arden Hill Hospital and Horton 
Medical Center in Middletown, N.Y.
Jason E. Roth, M.D. '98, finished his 
residency in internal medicine at 
Eisenhower Army Medical Center at 
Fort Gordon, Ga., and stayed on as a 
staff physician in the internal medicine 
clinic. In June he was deployed to 
Bosnia as part of the International 
Peacekeeping Force. He married Amy 
Rowley on May 19,2002.
continued on page 35
Long Island Medical Group, 
now affiliated with North Shore 
University Hospital.
Victor Altchek retired six years 
ago. He performed his last 
operation on his last day of 
work, at age 76. “He was still 
sleeping at the hospital once 
a week and would have con­
tinued. But I told him, ‘You’re 
76, you’ve paid your dues,'”
Douglas Altohek says. But for 
Victor, doctoring was never 
about paying dues. It was 
about having the privilege of 
caring for people. As his son 
Douglas says, “None of us 
really made a lot of money in 
medicine, but we were never 
in it for the money. We’re in it 
to have a good time and help 
people along the way.” ♦
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Helping Children Function and Cope
Come with a Speech Language 
Pathology Degree
Robyn Rosenberg is one of 
those people who can't say 
no. When people aren’t asking 
for her help, she is looking for 
ways to help people. Since 
graduating from the Speech 
Language Pathology Program 
in the School of Public Health 
last year, she has found plenty.
Rosenberg, CCC-SLP '01 
(Certificate of Clinical Com­
petency in Speech-Language 
Pathology), teaches special 
needs children at Royle 
Elementary School in Darien, 
Conn. Her students’ disabili­
ties include autism, non-verbal 
learning disorder, Asperger’s, 
Rett and Prader-Willi syn­
dromes, cortical blindness 
and mental retardation. She 
works with kids on a wide 
range of skills: language, 
articulation, answering ques­
tions, critical thinking, problem 
solving, swallowing and mem­
ory. Many of these skills may 
appear unrelated to speech or 
language, but all of them— 
even memory—are con­
nected.
Rosenberg explains, “People 
typically store information in 
an organized manner by 
grouping things in their head. 
People with language difficul­
ties have trouble understand­
ing word meanings, so when 
they store information they 
don’t know how to recail it.’’ 
Oral-motor difficulties, like not 
being able to lift the tongue 
high enough to produce the 
sounds needed for word pro­
nunciation, are common 
among her students, and they 
must work on strengthening 
the muscles and elements in 
and around their mouths—the 
tongue, lips and jaw. Children 
who have trouble swallowing 
learn that turning their head or
tucking under their chin will 
trigger the swallowing reflex.
Rosenberg does more than 
teach children. She comforts 
and counsels parents who are 
coming to terms with their 
child’s disability. “I help par­
ents help their children be as 
successful as they can be,” 
she says. Speech Language 
Pathology students are 
required to take counseling, 
which is one of the program’s 
assets, she points out. “I had 
so much hands-on opportu­
nity at the College, with gross 
anatomy and cadavers and 
working in a hospital. Friends 
in other graduate programs 
used to call me and say, ‘We 
never took that class but you 
did, can you help me?”’
Rosenberg began sharing her 
knowledge of speech language 
pathology long before gradu­
ate school. As an undergradu­
ate in Ithaca College’s speech 
language program in Ithaca,
N.Y, she was asked to lecture
the entire physical therapy 
department on augmentation 
and alternative communica­
tion, techniques and tools that 
can help children communi­
cate, such as pictures, sign 
language, and computers.
She was also 
invited to lecture a 
; multicultural educa- 
: tion class about 
; working with non- 
: mainstream chil­
dren. “We have dif- 
i ferent populations 
in our classes,
I including people 
: with special needs,”
: she says. Even as 
I early as high school 
I Rosenberg volun- 
t teered her time,
( assisting in a 
I speech therapy 
I class where she 
I helped children 
P practice target 
sounds. That’s 
when she realized 
she wanted to work 
with kids like these.
What appealed to her was 
working in a regular school, 
where special needs children 
learn alongside those who 
don’t have special needs. It is 
a controversial approach to 
education. Some say that 
children learn best when 
grouped with peers who 
share function and skill levels. 
Others, like Rosenberg, argue 
that integrating disabled and 
non-disabled children 
enriches education for both. 
“Kids sometimes learn best 
from their peers. Plus, they get 
to socialize. They’re treated 
like they’re one of the gang,” 
she says. Fully functioning 
children benefit too, iearning 
skills they wouldn’t be exposed 
to ordinarily, as well as toler­
Robyn Rosenberg, CCC-SLP '01
ance, she says. “One of my 
kids is using modified sign 
language and some of the 
other kids are picking it up. 
How terrific is that?”
Outside the classroom, 
Rosenberg continues to 
share her knowledge and 
time. She led a district-wide 
staff development day on 
augmentation and alterna­
tive communication for 
teachers, social workers 
and other speech patholo-
“I help parents 
help their children 
be as successful 
as they can be.”
gists. She rewrote her 
school’s protocol for evalu­
ating students’ oral-motor 
skills. She is helping to run 
the Darien district’s new 
assistance technology lab, 
which furnishes the techni­
cal support—wheelchairs, 
occupational therapy tools, 
and voice output systems— 
to help students function. 
She is also supervising a 
second-year speech lan­
guage pathology student 
from NYMC. And, she is 
serving as the acting alumni 
president for the Speech 
Language Pathology 
Program.
“It’s such a great feeling to 
know that I have this back­
ground and I can share it,” 
Rosenberg says. “I’m a 
teacher. I’m a facilitator,




PAUL MIEYAL, PH.D. ’00
Brings Science and Business Together
If the word “scientist” conjures 
up an image of an introvert who 
wears taped-together horn­
rimmed glasses and stuffs 
pens in his shirt pocket, then 
you should meet Paul Mieyal.
Having shattered the stereo­
type of a scientist, he doesn’t 
come close to acting like an 
egghead. He also doesn’t 
work anywhere near a labora­
tory. Dr. Mieyal, who earned 
his Ph.D. in pharmacology in 
2000 at the Graduate School 
of Basic Medical Sciences, 
uses his scientific expertise to 
help Wechsler & Company,
Inc., a private investment firm 
in Mt. Kisco, N.Y., make sound 
investments in the biotechnol­
ogy industry. Some may say 
Meiyal abandoned the sci­
ence world for the business 
world. He says he’s got the 
best of both.
“There is a misperception that 
scientists in the business 
world have left science,” he 
says. “But scientists on the 
business side are exposed to 
a wide range of cutting edge 
scientific research. We 
become a little more clinical 
than research-oriented 
because we have to look at 
the applied side. I’m still 
exposed to cutting edge 
research that’s being done 
and therapies that are being 
developed. I’m just not per­
forming the experiments.”
An investment analyst. Dr. 
Mieyal evaluates the financial 
health of biotechnology com­
panies. He studies clinical 
data to see if the technolo­
gies, drugs or therapies they 
are developing are likely to be 
approved by the FDA and 
become profitable. “I get to be 
exposed to the intellectual 
side of science without taking 
the risks. Actually, I’m taking 
risks with someone else’s 
money,” he says.
As Dr. Mieyal sees it, the dif­
ference between science and 
business is the difference 
between idealism and practi­
cality. In the academic world 
there is more interest in what 
can be discovered. The busi­
ness world is more pragmatic.
Paul Mieyal, Ph.D. '00
“It doesn’t necessarily matter 
if something’s interesting. It 
has to be something you can 
commercialize, something 
there’s a demand for,” he 
says. And the demand must 
be substantial. “Ideally, a drug 
company would be able to 
work on drugs for every dis­
ease, whether it affects 10 
million or 1,000 people. But if 
you can only sell the drug to 
1,000 people, the pharmaceu­
tical company will go bank­
rupt,” he says. That’s where 
academic science comes in. 
“The responsibility is with 
academia to do the research 
because it’s not always feasi­
ble for a commercial com­
pany,” he explains.
Dr. Mieyal was headed for a 
career in academia—as a uni­
versity professor or a 
researcher at a pharmaceuti­
cal company—when he grad­
uated from Case Western 
Reserve University in 1993. 
While studying at New York 
Medical College and doing 
research in the pharmacology 
laboratory of John Quilley 
Ph.D. (now associate profes­
sor of pharmacology), he 
found himself wanting to 
app/y what he knew. “I started 
exploring career paths where 
I could still leverage my scien­
tific background,” he says. 
Already interested in busi­
ness, Dr. Mieyal took some 
basic accounting and eco­
nomics courses, hoping to 
find a job with a financial insti­
tution that needed his scien- » 
tific know-how. Wechsler & 
Company did. The firm hired 
him while he was defending 
his thesis and he’s been there 
ever since.
“There’s always something 
new,” he says. “I see a full 
range of medical applications 
that are coming out to treat 
every disease imaginable. I’m 
definitely able to use my sci­
entific background to under­
stand things.”
He has had to adjust, how­
ever. “In the lab I was active 
on my feet all the time, creat­
ing my own research and 
experiments. Now I spend 
time sitting in a chair at the 
computer, looking at others’ 
research and taking it at face 
value,” he says. Colleagues 
do make a little fun of him at 
work. “If I use any big words 
they like to call me an intellec­
tual,” he says, chuckling. But 
Dr. Mieyal—who doesn’t wear 
horn-rimmed glasses—stops 
the stereotyping there: “I usu­
ally wear contact lenses 
except at the computer. I can 
function at athletic events, and 
I’m proud to say I’ve never 
owned a pocket protector, but 
I’m still a scientist at heart.” ♦
MILESTONES
Geoffrey A. Booth, M.D. '99, has
Joined the internal medicine depart­
ment of the Sansum Santa Barbara 
Medical Foundation Clinic in Santa 
Barbara, Calif.
Heather Davis, M.S. ’99, who 
became a paramedic as an under­
graduate, is clinical coordinator for 
UCLA's Center for Prehospital Care 
in Los Angeles, Calif. Considered 
an EMS leader, she has spoken at 
national conferences, co-written a 
textbook, created a program for the 
LA County paramedics and served as 
an expert writer on the EMS Educator 
Curriculum Revision project.
1980s
Anthony Arciola, M.D. '80, has relo­
cated to Hudson and Valatie, N.Y. He 
welcomes communication with any 
alumni and wishes great success and 
happiness to all.
Nell D. Borack, M.D. '80, was 
awarded the Ronald Fleagan Founder’s 
Award from the Leadership of the 
Republican Party in the United States 
Senate in November 2001.
Melodie Morgan-Minott, M.D. '80,
is a private practice psychiatrist at 
Western Reserve Medical Center in 
Kent, Ohio. She specializes in treating 
adults and seniors for anxiety, 
depression, bipolar disorder and 
issues related to aging. Dr. Morgan- 
Minott was selected by Cleveland 
magazine as a “top doc” for 2002.
Matthew J. Arduino, M.S. '81, works 
for the Centers for Disease Control and 
Prevention in Atlanta, Ga. In June he 
was awarded the Health and Human 
Services Secretary's Distinguished 
Service Award for the World Trade 
Center and Anthrax Emergency 
Response and Investigation Team,
He also won the CDC/ATSDR 
(Agency for Toxic Substances 
Disease Registry) Charles Shepard 
Science Award for Prevention and 
Control for Scientific Excellence for 
co-authoring an article, “Control of 
Vancomycin-Resistant Entercoccus 
in Healthcare Facilities in a Fiegion,” 
published last year in the New 
England Journal of Medicine.
Jeffrey Boscamp, M.D. '81, is
chief physician and chairman of the 
pediatrics department at The Joseph 
M. Sanzari Children’s Hospital at 
Hackensack University Medical Center 
in Hackensack, N.J. He is also the 
hospital's chief of infectious diseases
continued on page 36
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and an associate professor of pediatrics 
at the University of Medicine and 
Dentistry of New Jersey.
Gregory Walter, M.D. ’81, is an 
emergency medicine specialist at 
Palmyra Medical Centers in Albany,
Ga., where he lives with his family.
Herman Ambris, M.D. '82, is in solo 
practice at Assertive Rehabilitation 
Medical Services in Brooklyn, N.Y.
Vincent Panella, M.D., ’82, was named 
tbp-gastroenterologist in New York 
magazine's June 2002 issue, which 
featured the “Best Doctors in New York.”
Bruce W. Peek, M.D. ’82, board certi­
fied in internal medicine, cardiovascular 
diseases, and interventional cardiology, 
has joined the staff of the Verde Valley 
Medical Center in Cottonwood, Ariz.
He is also an adjunct clinical professor 
at Kirksville College Medical School 
in Phoenix.
John Cosgrove, M.D. ’83, was recently 
appointed to the Alumni Association's 
Board of Governors. He is on the staff 
of North Shore University Hospital in 
Manhasset, N.Y., where he does mini­
mally invasive breast and bariatric 
surgery. He is married to Patricia Barry, 
M.D. ’83, who is in a private breast 
imaging practice.
Mark J. Cerbone, M.D. ’84, Is director of 
emergency psychiatry at Saint Francis 
Hospital in Poughkeepsie, N.Y. He is 
married to Margaret Lehane, a nurse 
practitioner/psychiatric nurse at the, 
hospital.
Elizabeth Clark, M.D. ’85, is chief of 
the newly formed division of geriatric 
medicine in the department of medicine 
at Lenox Hill Hospital in New York City.
Jesse L. Sandlin, M.S. ’85, opened 
an orthopaedic medical practice in 
May 2002 with offices in Wheeling and 
Glen Dale, W. Va.
Marc Zisselman, M.D. ’87, was named 
one of the “Top Docs 2002” in the May 
2002 issue of Philadelphia magazine.
He specializes in geriatric psychiatry and 
lives with his wife and their two children 
in Philadelphia.
Gari D. Carabln, M.D. ’88, is a 
general ophthalmologist, affiliated with 
Hackensack Medical Center and Holy 
Name Hospital in New Jersey.
John Edmund Smith Jr., M.D. ’88,
was appointed in May 2002 to the 
hematology/oncology division in the 
department of medicine at Easton 
Hospital in Easton, Pa.
William V. Begg, III, M.D. ’89, was
nominated in June fpr the prestigious 
Dr. Melville G. Magida Award. Each year 
the Fairfield County Medical Association 
and The Richard and Hinda Rosenthal 
Foundation present the Magida Award 
to a physician under 40 who has shown 
“a notable capacity for treatment and 
care and a special sensitivity to patient- 
physician relationships." Dr. Begg, an 
emergency room physician at Danbury 
Hospital in Danbury, Conn,, is an active 
participant in the community, has spoken 
at various high schools on the deleterious 
effects of teenage drinking and partici­
pated on numerous panels to promote 
safe driving and rally against the use of 
drugs. He lives in Newtown with his wife 
and three young children.
Gene Conrad, M.P.H. ’89, formerly 
on the faculty of Wake Forest Medical 
University and New York Medical College, 
recently published a book, “Selecting and 
Monitoring a Nursing Home.’
Scott McLaughlin, M.D. ’89, is leaving 
Primary Care of Southbury (Conn.) to 
become director of Guilford Medical 
Associates, a rural access healthcare 
facility in Dover-Foxcroft, Maine.
1970s
William Bracciodieta, M.D. ’71, has
been named regional chief medical 
officer for Health Net of California and 
Health Net of Oregon. He will oversee 
medical and quality management for 
Health Net’s Western Region.
Robert A. Kaplan, M.D. ’71, has been 
appointed clinical professor of pediatrics 
at the University of California, Irvine. He 
was also elected outstanding voluntary 
faculty member there for the practice 
of pediatrics at Miller Children's Hospital 
of Long Beach, Calif.
Eric D. Weston, M.D. ’71, is a gastro­
enterologist with Digestive Disease 
Associates of Clearwatdt, Fla, He says 
his most recent milestone is becoming a 
grandfather to Daniel Drouzas Weston.
Ann M. Barbaccla, M.D. '72, recently 
became the first physician and woman 
to chair the Board of Governors at 
Mercy Medical Center in Rockville 
Centre, N.Y.
Lorey H. Pollack, M.D. ’72, has been 
reappointed chairman of obstetrics- 
gynecology at Mercy Medical Center in 
Ftockville Centre, N.Y.
Albert “Pat” Henry, M.D. ’73, and 
Pat Hutton, M.D., ’74, former medical 
school partners, share an orthopaedic 
practice in Orange Park, Fla. In addition
to having been a medical missionary in 
Kenya, Tanzania, and the Ivory Coast,
Dr. Henry plays trumpet and piano with 
the Clay Community Band, a group of 
doctors and nurses who enjoy making 
music together. He says his only regret 
about being a physician is not having 
enough free time to work on his music.
Adam Hurewltz, M.D. ’73, Is chief of 
pulmonary critical care at Winthrop 
University Hospital in Mineola, N.Y.
Alan Kohrt, M.D. ’73, is a clinical 
associate professor of pediatrics at the 
Children’s Hospital of Philadelphia and 
the University of Pennsylvania. Married 
and the father of seven, he is also the 
District III board member of the 
American Academy of Pediatrics.
Robert Davis, M.D. ’74, a psychiatrist 
in private practice in New York City, is 
also an artist. Dr. Davis exhibited his 
watercolor ink stamp collage work in 
September at the Salisbury Bank and 
Tmst in Lakeville, Conn, where he also 
has a home. He donated all proceeds 
from sales of his work to the Paul Taylor 
Dance Company.
Patrick M.J. Hutton, M.D. ’74, is vice 
speaker in the House of Delegates for 
the Florida Medical Association and the 
American Medical Association delegate 
for the State of Florida.
Robert Dawe, M.D. ’75, has been 
named chief of orthopaedic surgery at 
Bridgeport Hospital in Bridgeport, Conn, 
Dr. Dawe specializes in pediatric and 
spinal reconstmctive surgery and is a 
clinical instructor at Yale University 
School of Medicine in New Haven.
James J. LaRosa, M.D. ’75, was 
appointed in May to be medical director 
of the 425-bed Franklin Hospital Medical 
Center in Valley Stream, N.Y.
Eton Schwartz, M.D., ’75, has a
full-time, private psychiatry practice 
in Hartsdale, N.Y.
Brian Altman, M.D. ’76, is practicing 
orthopaedic medicine at the Columbus 
Center for Orthopaedics and Sports 
Medicine in Whiteville, N.C. He and his 
wife Kim have five children.
John Carmody, M.D. ’76, an 
orthopaedic surgeon, has opened a 
practice in Galax, Va., and joined the 
medical staff at Twin County Ftegional 
Hospital. Dr. Carmody lives in Galax 
with his wife Fran.
Edmund LaGamma, M.D. ’76, has
been appointed a consulting member 
to the medical staff of a Carmel, N.Y. 
hospital affiliated with the Putnam 
Hospital Center.
WORKING IN THE 
MIDDLE EAST
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airplanes. “As many as 6,000 
men would jump out of air­
planes and 1 percent would 
see me," he says.
Domestic duty for both doctors 
ended with the beginning of 
the U.S.-Afghanistan conflict. 
“Everything changed with 
September 11,” Dr. Hirshman 
says. Within three months of 
each other, he and Dr. Curran 
were deployed to the Middle 
East, each leaving behind a 
wife, child and baby on the 
way. Dr. Curran went to 
Uzbekistan, where he set up 
a small hospital and treated 
casualties among members of 
the Northern Alliance. Then 
he was off to Afghanistan, 
where he looked after 
detainees, conducted strip 
searches, provided dental 
and wound care and set up a 
clinic. Dr. Hirshman went to 
Kuwait, where he provided 
obgyn and basic medical 
care for military personnel, 
their families as well as U.S. 
allies.
Now discharged, both are 
home for good. Dr Hirshman 
is joining an obgyn practice 
in Dallas and spending time 
with his toddler Benjamin, and 
newborn son, Jory while his 
wife, also an obgyn, com­
pletes a residency in urology. 
“I’d been away for almost a 
year of Benjamin’s life. I didn’t 
think I could continue doing 
that,” he says.
Dr. Curran, who will be an 
emergency room physician at 
the Midstate Medical Center 
in Meriden, Conn., is happy tc 
be raising his sons, Brendan 
and Luke, without the 
prospect of having to uproot 
them. “It [the Army] was really 
demanding and prepared me 
for what the civilian world will 
throw me,” he says. “Now I’m 






Jack Rubenstein, M.D. 76, has
been appointed director of medicine 
at Franklin Flospital Medical Center 
in Valley Stream, N.Y., part of the 
North Shore Long Island Jewish 
Health System, Dr. Rubenstein is the 
senior physician and general partner 
at Internal Medicine Associates of 
East Hills, LLP, in Roslyn Heights.
He is a clinical associate professor 
of medicine at New York University 
School of Medicine, as well as a diplo­
mats in internal medicine, nephrology 
and geriatric medicine.
Scott Cutler, M.D. 77, and his wife, 
Robin, are delighted that their daughter, 
Beth, has entered the New York Medical 
College class of 2006.
Lucille C. Norville Perez, M.D. 79,
is an associate director at the NIH in 
Bethesda, Md. Dr. Perez is also the 
102nd president of the National Medical 
Association in Washington, D.C., the 
nation's oldest and largest association 
representing African-American doctors. 
She has belonged to the NMA for nearly 
20 years and is past chair of its commit-
I
tee on community medicine and public 
health.
I 1960s
Robert E. Hassler, M.D. ’60, is 
practicing obstetrics-gynecology in 
Shallotte, N.C.
Carl M. Marchetti, M.D. ’60, is a
senior vice president at the Jersey Shone 
Medical Center in Neptune, N.J. In a 
December 2001 logging accident his 
right thumb was amputated and 
successfully reattached and is now 
fully functional.
Paul Brenner, M.D. ’61, counsels the 
chronically III and teaches at the 
University of California, San Diego 
School of Medicine.
Stanley R. Sakowitz, M.D. ’62, is
practicing allergy and immunology and 
is the proud grandfather of Ari, age 4, 
and Talia, age 2.
Elliot Grau, M.D. ’64, is employed 
with Indian Health Services in Fort 
Totten, N.D. He plans to spend one or 
two more years there before retiring.
Dr. Grau and his wife, Jackie, live in 
Lakota, N.D.
Richard Allen, M.D. ’65, has been 
appointed the American Medical 
Association's representative to the 
American Board of Medical Specialties 
(ASMS). He also has been elected
I_____
vice-chair of the American College of 
Obstetrician Gynecologists (ACOG) 
section to the AMA. He is a clinical 
professor in the department of 
obstetrics-gynecology at Oregon 
Health Sciences University.
Qwie T. Chew, M.D. ’65, having retired 
from full-time radiology practice, plans 
to travel and pursue other interests,
Franklin L. DiSpaltro, M.D. '65,
has been named president of the 
American Society for Aesthetic Plastic 
Surgery (ASAPS), which represents 
close to 1,900 board-certified plastic 
surgeons who focus on cosmetic 
surgery. Dr. DiSpaltro is an attending 
physician in the department of plastic 
and reconstructive surgery at Saint 
Barnabas Medical Center in Livingston, 
N.J., and a member of its Board of 
Trustees.
Kathleen M. Perry, M.D. ’67, is an
obstetrician-gynecologist with a 
private practice, Richmond Gynecology, 
in Ftandall Manor, N.Y. She is also a 
senior attending physician in obstetrics- 
gynecology at Staten Island University 
Hospital and has received the American 
Medical Association’s Physicians’ 
Recognition Award six times.
David Herz, M.D. ’69, is director of 
neuroscienoes at Saint Mary’s Mercy 
Medical Center In Grand Rapids, Mich. 
He is also a practicing clinical neuro­
surgeon and professor of surgery at 
Michigan State University.
Richard N. Hirsh, M.D. ’69, brought a 
mammography-teaching mission to 
Hanoi, Vietnam in May 2002. He is 
organizing a breast cancer conference 
for the National Institute of Oncology in 
Havana, Cuba, which will take place 
Febaiary 2-8, 2003.
1950s
Michael L. Daly, M.D. ’57, retired 
from the University of Minnesota 
family practice department in 1995.
He spends his time building and using 
canoes and kayaks and playing with 
his 13 grandchildren, Including a set 
of triplets.
Joan Easton, M.D. ’57, is working 
part time, traveling, playing tennis, and 
enjoying it.
Robert J. Blankfein, M.D. ’58, retired 
from the practice of neurology on June 
30, 2002. He and his wife are enjoying 
retirement, including swimming and 
ballroom dancing.
..................
Salvator Altchek, M.D. ’34,
died on September 10, 2002.
He was 92.
M. Paul Lazar, M.D. ’47, died on 
September 24, 2002. He was 79, 
Franklyn J. Simecek, M.D. ’47,
died on June 11,2001 at Emerald 
Ridge Nursing Home in Solon, 
Ohio. He was 78.
John D. Gossel, M.D. ’50, died 
on May 14, 2002 at the Holmes 
Regional Medical Center in 
Melbourne, Fla. He was 86.
John P. Murphy, M.D. ’50, died 
on July 31, 2002 at Greenwich 
Hospital in Greenwich, Conn,
He was 83.
Meredith Montague III, M.D. ’51,
died on November 8, 2002 in 
Houston, Texas. He was 77.
Henry Francis Stoltmann, M.D.
’54, died on July 2, 2002 at 
Needham Nursing Home in 
Needham, Mass. He'was 73.
H. Jeff Zeidner, M.D. ’57, died 
on April 20, 2002.
Edgar A. Parmer, M.D. ’58, died 
on September 5, 2002. He was 73. 
Edward Pendagast Jr., ’58, 
died on September 17, 2002 at 
his home in Easton, Conn. He 
was 70.
Robert S. Schindler, M.D. ’58,
died on August 26, 2002. He 
was 72.
Eugene Harbilas, M.D. ’62,
died on September 29, 2002.
He was 70.
Jack M. Clemente Jr, M.D. ’63,
died on October 21,2002 at St. 
Barnabas Medical Center in 
Livingston, N.J. He was 64.
Willard D. Smith, Jr, M.D. ’69,
died in May 2002.
Mary Judith Murphy, M.D. '78,
died on May 16, 2002, at the age 
of 59.
Faculty
Roy Hertz, M.D., professor of obstetrics and gynecology from 1972-1973, 
died on October 28, 2002, in Hollywood, MD. He was 93. Dr. Hertz won 
an Albert Lasker Medical Research Award in 1972 for co-discovering a 
treatment for choriocarcinoma, a highly malignant cancer originating in 
the placenta of pregnant women.
Milton Terris, M.D., former chairman of the Department of Community 
and Preventive Medicine, died at his home in South Burlington, Vt. on 
October 3, 2002. He was 87. Dr. Terris headed the department for more 
than a decade and stepped down in 1980. He founded and was past 
president of the National Association for Public Health Policy and the 
Society for Epidemiological Research. He also founded the Journal of 
Public Health Policy and had been its editor for more than 20 years.
Calendar of Events
January 26 - 30, 2003
Winter CME Seminar 
Dorado, Puerto Rico
May 17, 2003
Annual Alumni Banquet 
The Plaza Hotel, New York City
May 18, 2003




Carnegie Hall, New York City
For additional information, 
please call the Alumni Office at (914) 594-4556.
Paging all Doctors!
If you worked on Welfare Island (now Roosevelt Island) before 1973, 
the Roosevelt Island Historical Society wants to hear from you! Please 
contact Judith Berdy, president, at 212-688-4836 and add your story, 
photos, writings and memorabilia to the society’s historical archives.
We’re on the Web
Visit us at http://www.nymc,edu/alumni/ and tell us about yourself. And 
don’t forget the Home Page (www.nymc.edu) for the latest College news.
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